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1 Introduction 
“Beauty lies in the eyes of the beholder” - Plato 
Every human being has different inclinations on what is beautiful. However, for a majority 
of people, beauty may be skin deep. A radiant and rash-free skin contributes towards an 
individual's overall appearance largely. Fashion industry thrives on jewelry, cosmetics and 
fragrances. But on a dermatological perspective, jewelry metals and perfume ingredients 
top the list of substances most likely to cause contact dermatitis [1]. There is a steady rise 
in the incidence of contact allergy over the last few centuries due to industrialization [2]. 
Thus, in this modern era, the innate immune system in association with the skin, has to 
defy all odds to tackle the challenges posed by a variety of natural and synthetic chemicals.  
1.1 Innate immunity and the skin 
Immunity has evolved into an intriguing system comprising both innate and adaptive 
components, which must operate in tandem against a plethora of noxious substances to 
protect the host. The innate immune responses work via distinct modules in order to 
protect against pathogens. Pattern-recognition receptors (PRRs), the most critical 
component of this system, sense the pathogen and activate the antimicrobial defences [3].  
 
PRRs distinguish the molecular signatures present in various microbes via pathogen-
associated molecular patterns (PAMPs) and so far identified PRRs include Toll-like 
receptors (TLRs), Nod-like receptors (NLRs) and RIG-I-like helicase receptors (RLRs) 
[4]. Indeed, the discovery of TLRs shattered several misconceptions and rightly pointed 
out that the innate immune responses show a high degree of target specificity. Moreover, 
PRRs are completely germline encoded and have been selected by evolution to recognize 
pathogen-derived compounds that are essential for pathogen survival or endogenous 
molecules that are released by the host in response to infection [5]. They are widely 
expressed in immune as well as non-immune cells, unlike the T cell and B cell antigen 
receptors. These innate immune receptors have been identified in the serum, on the cell 
surface, in endosomes, and in the cytoplasm [5].  
 
Once a specific PAMP is detected, PRRs unleash a stringent array of innate immune 
responses subsequently followed by priming antigen-specific adaptive responses [6]. 
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Apart from their primary function in innate immunity, PRRs are also involved in the 
pathogenesis of numerous diseases including auto-immune disorders, chronic 
inflammatory conditions like asthma and allergy, renal dysfunction and in some types of 
cancers [7-11].  
 
Skin is a dynamic organ, though in the past it was just regarded as a passive wall guarding 
the internal organs and tissues [12]. Being the largest organ of the human body, it is the 
most accessible cover to the environment [13]. It offers the first line of protection against 
a wide range of physical and biological assaults [11]. As in other organs, toxic substances 
that encounter the skin are recognized by PRRs. Recent findings reveal that the skin is 
associated with complex functionalities in order to maintain homeostasis. The distinct 
feature of the skin to perform multifaceted tasks is definitely due to its structural 
organisation.  
 
Skin is composed of two distinct layers namely the outer epidermis and an inner dermis, 
isolated by a basement membrane. The epidermis is arranged outwardly by layers of the 
stratum basale, the stratum spinosum, the stratum granulosum, and the stratum corneum 
with the latter consisting of keratinized squamous epithelial cells referred to as 
corneocytes [14]. 
 
Keratinocytes, Langerhans cells, melanocytes and Merkel cells are the resident cell types 
found in the epidermis [11]. Primary function of the keratinocytes is to proliferate and 
maintain the outer layer of epidermis with a stratified epithelial zone and a water-resistant 
layer of lipids. The melanocytes are crucial for the biosynthesis of melanin thereby 
rendering uniform skin pigmentation as well as protection against UV radiation [11]. The 
intraepithelial T lymphocytes and Langerhans cells that serve as cutaneous antigen 
presenting cells (APCs) are interspersed between the keratinocytes and melanocytes. 
Merkel cells are oval sensory cells often known as nerve-ending cells, essential for light-
touch and discrimination of shapes and texture [14]. They may have a neuroendocrine 
function as well. The connective tissues anchor the epidermis beneath to dermis. The 
dermis is highly vascularised and has a rich amount of nerve fibres, macrophages, 
fibroblasts and lymphocytes. The epidermal cell types express a varied range of TLRs, 
which respond to their ligands by activating the proinflammatory nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB) pathway leading to the release of 
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cytokines [15]. Several studies report that keratinocytes express TLRs 1, 2, 3, 5, 9 and 10 
[16-19], while there is conflicting data regarding TLR4 expression [16, 19].  
1.2 Allergic contact dermatitis 
Contact dermatitis is one of the most prevalent skin diseases, with significant socio-
economic impact [20]. In Europe, about 20% of the general population suffers from 
contact allergy to at least one contact allergen [21]. Based on the molecular mechanism 
involved, two main types of contact dermatitis may be distinguished. Irritant contact 
dermatitis develops due to the proinflammatory and toxic effects of xenobiotics able to 
activate the innate immunity of the skin whereas allergic contact dermatitis (ACD) 
requires the activation of hapten-specific acquired immunity leading to the development 
of effector T-cells, which mediate the skin inflammation. ACD accounts for about 10% of 
all the dermatological disorders and about 50% of all occupational skin diseases [22]. 
ACD is defined as an inflammatory reaction of the skin caused by repeated exposure with 
harmful exogenous substances [23]. Contact allergens are widespread in the environment 
and it may be of natural or synthetic origin. Presently, more than 4000 contact allergens 
are known [24].  
 
Hypersensitivity reactions are classified into four categories namely type I, II, III and IV 
[25]. Being a type IV delayed hypersensitivity reaction, ACD is the most common 
immunotoxicity seen among humans [26]. Contact allergy evolves through a cascade of 
intriguing immune-mediated processes made up of two distinct phases, namely the 
afferent/sensitization phase and the elicitation phase [27]. Primary prevention of ACD is 
aimed at minimizing the risk of induction, whereas secondary and tertiary prevention are 
targeted to reducing elicitation. In the afferent or sensitization phase, the skin is primed 
by the topical exposure to a concentration of the allergen, which may be sufficient to 
trigger the immune response. However, in some cases the hapten itself may not be able to 
generate innate immune activation but with the help of a coincident infection. Upon re-
exposure to the same allergen, there is an onset of a rapid and aggressive secondary 
immune response. In the elicitation phase, T cells play a crucial role in the innate immune 
response. Amplification of the immune response is brought about by the release of an 
array of proinflammatory and chemotactic factors resulting in the stimulation of local 
blood vessels through the recruitment of mast cells, macrophages and neutrophils [28, 29]. 
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Clinical manifestation of ACD requires a minimum period of 48 h [30, 31]. The acute 
inflammatory skin response is also known as eczematous dermatitis and its morphology 
ranges from a milder erythema to a severe edema. Upon removal of the contact allergen, 
these symptoms disappear [32]. 
 
Studies on genetic and immunological factors in contact allergy are hampered by the fact 
that mechanisms may vary for sensitization and elicitation and different allergens may 
induce different pathways [33]. For a majority of contact allergens, the basic principles of 
ACD have been understood while the sensitization and elicitation processes are still 
unclear at the molecular level. 
1.2.1 Etiology and clinical significance 
Common causes of ACD include metal allergens, fragrances, rubber, dyes, preservatives 
and poison ivy [13]. Among the metals allergens, allergies to nickel (Ni2+), cobalt (Co2+) 
and chromium (Cr6+) are the most prevalent form [34]. Palladium and gold, are also known 
to cause ACD [35-37]. The occurrence of ACD for metal allergens Ni2+, Co2+ and Cr6+ 
was about 15%, 5% and 3%, respectively [38]. The rate of Ni2+/Co2+ induced ACD is 
higher at younger age, while the prevalence of Cr6+ ACD remained high for the whole life 
[39]. The prevalence of ACD in the German population is reported to be 8% in men and 
21% in women [21]. Metal ions differ from the classical haptens in its binding with partner 
molecules by forming reversible, well defined coordination complexes [40]. 
 
The most common cause of ACD in women is Ni2+ in many countries around the world 
[41]. Being a potent environmental pollutant and as such several Ni2+-compounds are 
carcinogenic, exposure to this heavy metal may lead to severe health hazards [42]. In 
industrialized countries, up to 40% of young females and increasingly males are sensitized 
to Ni2+ and develop allergic dermatitis upon contact with Ni2+-releasing metal alloys such 
as costume jewelry, body piercings and coins [43-45]. Women are more predisposed due 
to usage of high Ni2+-content jewelry [46]. Ear piercing is considered as the primary 
reason for the high prevalence. 
 
Cobalt is ubiquitous in the environment because of its broad usage in metallurgical and 
electronic industries, magnetic alloys production and the building construction sector. 
Most common sources of Co2+ include ceramics, paints, jewelry, hair dyes and fertilizers 
5 
 
[47]. Co2+ has also been detected at significant levels as air pollutant and exerts numerous 
biological effects apart from ACD, including mimicking of hypoxia systemically [48]. 
 
Moreover, the usage of these allergens is alarming in the context of biocompatibility of 
cardiovascular stents, orthopaedic and dental biomedical alloys [49-51]. The 
understanding of how these metal allergens exert their toxic and allergic effects at a 
molecular level may be important in risk assessment, as well as in the treatment and 
prevention of occupational diseases. 
1.2.2 Occupational contact dermatitis and economics 
Occupational contact dermatitis (OCD) ranks first among occupation-related diseases in 
many countries [52]. The annual incidence rate reported for OCD is 0.5-1.9% [53]. 
Epidemiological studies play an important role in observing disease trends, analysing risk 
factors, and monitoring the effect of preventive measures. The most affected professions 
include construction workers, cashiers, hair-dressers, healthcare workers, employees in 
the food industry, cleaners and metallurgy workers [54]. Importance of ACD is not only 
related to the high incidences worldwide, but also to the high costs for health care systems 
and the economy as well as in an impairment of the quality of life for the patients. In this 
context, people with ACD of the face or those who are obliged to change job reported the 
worst quality of life [55]. 
1.3 Molecular mechanisms of metal-induced ACD 
The key mechanism by which metal allergens induce ACD is a T cell-mediated reaction 
with production and release of various cytokines [56]. Ni2+ possesses irritant capacity and 
triggers a direct innate immune signal associated with activation of proinflammatory 
signaling pathways. A previous study from our laboratory has shown that Ni2+ is able to 
cause a rapid induction of endothelial activation markers as early as 8 h after ACD 
elicitation in sensitized individuals, a time point well before Ni2+-reactive T cells and other 
leukocytes infiltrate the skin [57]. 
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1.3.1 Endothelium and inflammation 
Endothelium, strategically located between the blood and the tissue compartments, is an 
important component of the innate immune system. It has long been considered as only a 
physical barrier between the extra- and intravascular space. Recent studies reveal that the 
endothelium is an independent and metabolically active organ. It is involved in the 
regulation of blood pressure, the mass transfer between blood and tissue, coagulation, 
angiogenesis and in several immunological processes [58]. The role of endothelial cells 
(ECs) in inflammatory processes is of particular interest in the present work. Activation 
of ECs by endogenous or environmental factors is a crucial step in the initiation of 
inflammatory responses [59, 60].  
 
Inflammation is an immune reaction caused by injury or tissue damage and characterized 
by redness, heat, swelling, and pain. The primary objective of inflammation is to localize 
and eradicate the irritant and repair the surrounding tissue. Ligand interactions between 
endothelium and leukocytes play a vital role in the regulation of cellular trafficking at the 
site of immunologic challenge [61]. Clinically, inflammation is characterized by dilation 
of connected arterioles, venules and capillaries with an increased blood flow, increased 
permeability of the blood vessels to cells and soluble components from the blood and the 
trans-endothelial migration of leukocytes into the surrounding tissue. Cause of this chain 
of reactions is the expression of soluble and cell surface-bound proteins, such as 
chemokines, cytokines, and adhesion molecules by the endothelial cells [62-65]. 
 
In primary human ECs, metal allergens have been shown to activate proinflammatory 
signaling cascades such as the NF-B pathway [66]. NF-κB, which was first described in 
1986 [67], has become a collective term for structurally related homo-and heterodimeric 
transcription factors of the Rel family. These are highly conserved among different 
species, and play a central role in the transcriptional control of rapidly inducible proteins 
[68, 69]. NF-κB is located in the cytosol as an inactive complex of the NF-κB dimer 
coupled with an inhibitory protein I-κB kinase (IKK). This classic "NF-κB" dimer consists 
of p65 and p50 subunits. The IKK complex entails two kinases IKKα and IKKß and a 
regulatory subunit NEMO (NF-κB essential modulator), also called as IKKγ [70]. 
Phosphorylation of the IKK complex at two serine residues (Ser32 and Ser36) leads to the 
ubiquitination and degradation of IKKα. The release of NF-κB from its inhibitory protein 
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leads to the translocation of the transcription factor into the nucleus where it binds to the 
promoter region of its target genes [71, 72] (Fig. A).  
 
 
Fig. A: A schematic representation of NF-B activation. In response to an extracellular signal, IL-1R or 
TLRs induces the IKK complex mediated NF-B activation. Modified adaptation from Janssens and Beyaert 
(2003) [73]. 
 
Normally, the activation of NF-B leads to the expression of a variety of gene products, 
especially inflammatory cytokines, chemokines, cell adhesion molecules and 
immunoregulatory surface molecules [74]. This triggers a rapid immune response finally 
leading to a systemic activation of the immune system. Thus, the transcription factor  
NF-B functions as a gene switch and central coordinator of the immune response. 
 
In the case of metal allergens, NF-B activation finally leads to the synthesis and secretion 
of proinflammatory adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. These 
adhesion molecules are required for leukocyte recruitment to the site of exposure [66]. 
Preliminary observations ascertained that co-stimulation with irritants or unlinked haptens 
during the sensitization or elicitation phase allows induction of contact hypersensitivity 
(CHS) [75-77]. The degree of the induced innate immune signal critically determines the 
responsiveness to a given contact allergen [78]. For instance, adequate induction of an 
innate immune signal during the sensitization phase of CHS is required for appropriate 
activation and deployment of dendritic cells (DCs). In turn clonal expansion of hapten-
specific T-effector cells are mediated by DCs in the dermal lymph node [79]. Failure to 
induce hapten-specific T cells results in tolerance due to improper activation of DCs [80]. 
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Therefore, better knowledge of the molecular mechanisms by which haptens activate the 
innate immune system is crucial to establish novel therapeutic strategies. 
 
The clinically asymptomatic sensitization phase of ACD is well documented while the 
mechanisms involved in the elicitation phase are poorly understood [81, 82]. It is currently 
believed that cutaneous application of an allergen (hapten) induces two equally important 
signals for the elicitation of contact eczema. The initial signal is a hapten-specific signal 
that involves the action of hapten-specific T lymphocytes whereas the second one is a non-
specific proinflammatory signal resulting in the induction of cytokines, chemokines and 
adhesion molecules that contribute to the recruitment of hapten-specific T lymphocytes to 
the skin (Fig. B). 
 
 
Fig. B: Diagrammatic representation of efficient development of ACD requiring both a T-lymphocyte-
specific signal and a proinflammatory immune signal. 
 
From the current understanding, it is uncertain how cells identify the proinflammatory 
signal provided by the hapten. Some haptens can deliver this innate immune signal 
independently, while weak allergens may depend on unrelated stimuli such as a 
microlesion or a coincidental infection to exert their full allergic potential [20]. A recent 
study showed that innate immune receptors in the form of TLRs have a crucial role in the 
development of contact hypersensitivity, the mouse model of ACD [83]. Moreover, one 
of our preliminary studies revealed that the Ni2+ induced CCL2 (or MCP-1) expression 
was blocked when using a dominant negative IL-1 receptor-associated kinase 1 (IRAK-1) 
(Fig. C). It is very well known that IRAKs play a vital role in both IL1R and TLR signaling 
[84]. However, IRAK1 mediated IL-1 signaling could be excluded as IL-1 neutralizing 
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antibodies did not block the response of this metal allergen [66].  Therefore, it is very clear 
that a TLR might be involved in the elicitation of metal induced eczema. 
 
 
 
Fig. C: Abrogation of Ni2+-induced expression of NF-B target gene CCL2 by a dominant negative mutant 
of IRAK1 (IRAK1-DD). Intracellular expression of CCL2 was analysed by flow cytometry after stimulating 
ECs with Ni2+ (1.5 mM) or IL-1ß (100 U ml-1) or TNF (2 ng ml-1). The colored (red or blue) profiles indicate 
the CCL2 expression while white outline profile represents the isotype controls. Cells were gated on GFP+, 
which was co-transfected to determine the transfection efficiency. Data represents two independent 
experiments. Data courtesy: Prof. Dr. M. Goebeler and S. Schmid. 
 
1.3.2 The TLR system 
Until now the existence of 10 and 12 TLRs are reported in human and mice, respectively 
[85]. TLRs are highly conserved from Drosophila to humans and share structural and 
functional similarities. Immune cells like monocytes or DCs express various TLRs but 
somatic cells like keratinocytes also express some TLRs [11]. These receptors belong to 
the class of type-I transmembrane glycoproteins [86] and are localised on the plasma 
membrane, the endocytic vesicle membrane, or intracellular organelles [87]. Structurally, 
TLR paralogs are composed of extracellular, transmembrane and intracellular signaling 
domains. The ligand recognition is attributed to the repeated leucine-rich repeats (LRRs) 
found on the ectodomain [88]. Additionally, accessory molecules may also be involved in 
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ligand binding in addition to a cytoplasmic toll/interleukin-1 (IL-1) receptor (TIR) 
domain, which interacts with TIR-domain-containing adaptor molecules [87]. 
 
TLR4, the founding member of TLR family, was identified as the receptor for 
lipopolysaccharide (LPS), a structural component of the outer membrane of Gram-
negative bacteria [89]. The receptor binds to its co-receptor MD2 (also known as 
lymphocyte antigen 96), on the cell surface, and serves as the main LPS-binding 
component [90]. Recent biophysical studies on the LPS-bound TLR4 complex has shown 
that five of the six lipid chains of the ligand binds to the hydrophobic pocket of MD2, and 
the remaining lipid chain that is exposed to the surface on MD2 associates with TLR4 [91, 
92].  
 
The resulting formation of a receptor multimer composed of two copies of the TLR4-
MD2-LPS complex (Fig. D) initiates signal transduction by recruiting intracellular 
adaptor molecules. Additional proteins such as LPS-binding protein (LBP) and CD14 are 
also involved in LPS binding [90]. Stimulation of TLR4 by LPS, activates myeloid 
differential factor 88 (MyD88) and TIR domain-containing adapter inducing IFN-beta 
(TRIF)-dependent signaling pathways leading to activation of NF-B and IFN-regulatory 
factor 3 (IRF3) [93].  
 
 
 
Fig. D: Depiction of a symmetrical dimer structure of the TLR4–MD2–LPS complex. The primary interface 
between TLR4 and MD2 is formed before binding LPS, and the binding of LPS induces the dimerisation 
interface. TLR4 is divided into N-, central and C-terminal domains [91]. The LRRNT and LRRCT modules 
cover the amino and carboxy termini of the LRR modules. Modified adaptation from Park and colleagues 
[92]. 
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1.4 Objectives 
 
Cobalt and nickel share similar chemical properties as they are adjacent to each other in 
the periodic table of elements [94]. Similar to Ni2+, Co2+ has also been shown to have 
irritant capacity and elicits a direct innate immune signal resulting in the activation of 
proinflammatory cascades such as the IKK2/NF-B pathway in primary ECs [66]. The 
effects of the metal allergens Ni2+ and Co2+ thus resemble those induced by 
proinflammatory cytokines such as TNF or IL-1ß that activate NF-B pathways in ECs. 
However, it is presently unclear how exactly these metal allergens trigger the upstream 
molecules of the NF-B pathway. Likewise, there is not enough data for the 
proinflammatory responses to Ni2+/Co2+ in other relevant cell types and species.  
 
Therefore, the main goal of this study is to elucidate the sensory mechanisms by which 
metal allergens Ni2+ and Co2+ induce its proinflammatory responses that foster the 
development of allergic reactions. Based on our preliminary data, it is evident that a TLR 
complex might be involved in the sensory process to these metal allergens, we particularly 
would like to address the following questions 
 
a) Which TLR is involved in the elicitation of the metal allergies? 
b) Can these metals directly interact/bind with the TLR or its co-receptor? 
c) Is the mechanism of activation common for both the metal allergens? 
 
We are also interested in the elucidation of novel targets for therapeutic intervention with 
contact allergy responses of the skin. 
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2 Material 
 
2.1 Chemicals 
 
All standard chemicals and reagents were purchased from AppliChem (Darmstadt), Fluka 
(Neu-Ulm), Merck Millipore (Darmstadt) and Roth (Karlsruhe), unless stated otherwise. 
 
2.2 Buffers and solutions 
 
Common laboratory solutions and buffers were prepared according to protocols described 
by Sambrook et al. [95]. The buffer solutions required for performing the experiments are 
listed below: 
 
2.2.1 Buffers and solutions for western blot and gel electrophoresis 
 
 4 x Laemmli-sample buffer 
250 mM Tris-HCl (pH 6.8), 8% sodium dodecyl sulphate (SDS), 40% glycerol,  
10% -mercaptoethanol, 0.01% bromophenol blue in double distilled (dd) H2O 
 Running gel buffer 
0.75 M Tris-HCl (pH 8.8), 0.2% SDS in dd H2O 
 Stacking gel buffer 
0.25 M Tris-HCl (pH 6.8), 0.2% SDS in dd H2O 
 1 x SDS-polyacrylamide gel electrophoresis (PAGE) buffer 
25 mM Tris-HCl, 192 mM glycine, 0.1% SDS in dd H2O 
 1 x blotting buffer 
25 mM Tris-HCl, 192 mM glycine, 20% methanol in dd H2O 
 1 x Tris-buffered saline (TBS) 
20 mM Tris-HCl, 137 mM sodium chloride in dd H2O, pH adjusted to 7.6 with 
concentrated HCl  
 1 x TBS-tween 20 (TBS-T) 
0.05% tween 20 in 1 x TBS 
 Milk powder – blocking buffer 
5% non-fat dry milk powder in 1 x TBS 
 Stripping buffer 
100 mM -mercapto-ethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.7) in dd H2O 
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 6 x sample buffer for agarose-gel electrophoresis 
0.25% bromophenol blue, 40% sucrose in dd H2O 
 1 x Tris acetate EDTA (TAE) - buffer 
Commercially available 50 x TAE buffer (Thermo Fisher, Darmstadt) was diluted in 
dd H2O. 
 E1A lysis buffer (ELB) 
150 mM sodium chloride, 50 mM HEPES (pH 7.5), 5 mM EDTA, 0.1% NP-40 in 
dd H2O; Before use, add freshly 20 mM -glycerophosphate, 0.5 mM sodium 
orthovanadate and 1 x complete protease inhibitor (Roche, Mannheim). 
 Enhanced chemiluminescence (ECL) detection buffer 
Solution A: 0.1 M Tris-solution (pH 8.5) freshly supplemented with 2.5 mM luminol, 
0.4 mM p-coumaric acid 
Solution B:  0.1 M Tris-solution (pH 8.5) freshly supplemented with 0.18% H2O2. 
Prior to detection, solution A and B were mixed and blots were incubated immersed 
for 1 min. 
 
2.2.2 Buffers and solutions for transfections 
 
 2 x HBS-buffer 
280 mM sodium chloride, 10 mM potassium chloride, 1.5 mM disodium-hydrogen 
phosphate, 12 mM glucose, 50 mM HEPES in dd H2O; adjust pH to 7.05 with NaOH; 
sterile filtered. 
 2.5 M calcium chloride solution; sterile filtered 
 1 mM HEPES in PBS; sterile filtered 
 10 mg ml-1 DEAE-Dextran in dd H2O; sterile filtered 
 100 mM Chloroquine in dd H2O; sterile filtered 
2.3 Stimulants and inhibitors 
 
Stimulant Concentration Company 
Recombinant TNF 2 - 5 ng ml-1 R&D (Minneapolis, USA) 
Recombinant IL-1 10 - 100 U ml-1   R&D (Minneapolis, USA) 
LPS 055:B5 from E. coli 1 µg ml-1 Sigma-Aldrich (Deisenhofen) 
LPS R595 from S. minnesota 1 µg ml-1   Enzo (Lörrach) 
LPS 026:B6 from E. coli 1 µg ml-1   Sigma-Aldrich (Deisenhofen) 
Nickel chloride (NiCl2.6H2O) 1.5 mM Merck (Darmstadt) 
Cobalt chloride (CoCl2.6H2O) 1.5 mM Sigma-Aldrich (Deisenhofen) 
Brefeldin A 0.2 µg ml-1   Calbiochem (Darmstadt) 
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Inhibitor Concentration Company 
Polymyxin B-sulphate (PMB) 50 µg ml-1   Sigma-Aldrich (Deisenhofen) 
2.4 Antibodies 
2.4.1 Antibodies used for western blot / immunoprecipitation 
 
Primary antibody Dilution Company 
Mouse anti-IL-8  1 g ml-1   BD Pharmingen (Franklin Lakes, 
USA) 
Mouse anti-alpha-Tubulin   1:10000 Sigma (St. Louis, USA) 
Mouse anti-FLAG M2  1:2000 Sigma (St. Louis, USA) 
Rabbit anti-FLAG 1:2000 Rockland (Gilbertsville, USA) 
Rat anti-HA (high affinity) 50 ng ml-1   Roche (Mannheim) 
Mouse anti-HA (12CA5) 1 g ml-1   Abgent (San Diego, USA) 
Rabbit anti-ERK2 1:2000 Santa Cruz Biotechnology (Santa 
Cruz, USA) 
 
Secondary antibody Dilution Company 
Sheep anti-mouse HRP 1:2000 GE Healthcare (Munich) 
Donkey anti-rabbit HRP 1:2000 GE Healthcare (Munich) 
Goat anti-rat HRP 1:2000 Santa Cruz Biotechnology (Santa 
Cruz, USA) 
 
2.4.2 Antibodies used for flow cytometry 
 
Primary antibody Dilution Company 
Mouse anti-IL-8 1:100 BD Pharmingen (Franklin 
Lakes, USA) 
Rat anti-HA 1:100 Roche (Mannheim) 
Mouse anti-TLR4 1:100 BioLegend (San Diego, USA) 
Mouse IgG isotype control 1:100 Dako (Hamburg) 
 
Secondary antibody Dilution Company 
Donkey anti-mouse Cy5 1:200 Dianova (Hamburg) 
Anti-rat FITC 1:250 BD Pharmingen (Franklin 
Lakes, USA) 
 
2.5 Kits 
Kit name 
Company 
Qiagen plasmid kits (mini, midi, maxi) Qiagen (Hilden) 
QIAquick gel extraction kit Qiagen (Hilden) 
DyeEx 2.0 spin kit Qiagen (Hilden) 
BigDye terminator cycle sequencing kit Thermo Fisher (Darmstadt) 
BD OptEIA human IL-8 ELISA set BD Pharmingen (Franklin Lakes, USA) 
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BD OptEIA mouse TNF ELISA set BD Pharmingen (Franklin Lakes, USA) 
Dual-Glo luciferase assay system Promega (Madison, USA) 
Quick start Bradford dye reagent BioRad (Munich) 
RNeasy mini kit  Qiagen (Hilden) 
High Fidelity cDNA synthesis kit  Roche (Mannheim) 
Quick-change II site directed mutagenesis kit  Stratagene-Agilent (Böblingen) 
RT2 First Strand Kit (qRTPCR array) Qiagen (Hilden) 
2.6 Transfection reagents 
Reagent 
Company 
DEAE-dextran Sigma (Taufkirchen) 
Lipofectamine 2000 Thermo Fisher (Darmstadt) 
FuGENE HD Roche (Mannheim) 
Oligofectamine Thermo Fisher (Darmstadt) 
Calcium chloride Sigma (Taufkirchen) 
2.7 Cell culture materials 
2.7.1 Media and media additives 
 
Media/Additives Company 
Endothelial cell basal medium (EBM) Lonza (Wiesbaden) 
EGM-SingleQuot supplements and growth factors Lonza (Wiesbaden) 
Dulbecco’s Modified Eagle's Medium (DMEM) + 
glutaMAX I 
Gibco (Karlsruhe) 
Medium M199 with Earle's salt GE Healthcare (Munich) 
RPMI 1640 medium + glutaMAX I  Gibco (Karlsruhe) 
OptiMEM I reduced serum medium Thermo Fisher (Darmstadt) 
Foetal bovine serum (FBS) PAA (Pasching) 
100 x penicillin/streptomycin (10.000 E / 
10 mg ml-1) 
Linaris (Wertheim) 
L-glutamine  Linaris (Wertheim) 
Gentamycin Sigma (Taufkirchen) 
Liquemine N5000 (heparin-sodium) Roche (Mannheim) 
100 x non-essential amino acids Biochrom (Berlin) 
Sodium pyruvate Sigma (Taufkirchen) 
Puromycin AppliChem (Darmstadt) 
Amphotericin B Sigma (Taufkirchen) 
 
2.7.2 Miscellaneous cell culture materials 
 
Reagent Company 
1 x Phosphate buffered saline (PBS) without 
Ca2+/Mg2+  
Gibco (Karlsruhe) 
Dimethyl sulfoxide (DMSO)  Serva (Heidelberg) 
10 x Trypsin/EDTA (0.5% / 0.2% in PBS) Pan (Aidenbach) 
Trypan blue Sigma (Taufkirchen) 
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Cell culture dishes Greiner (Frickenhausen) 
Cell culture flasks BD Falcon (Heidelberg) 
0.45 and 0.8 m syringe filter Sartorius (Göttingen) 
Microtiter plate (ELISA plates) Nunc (Wiesbaden) 
Microbank cryo tubes Nunc (Wiesbaden) 
2.8 Plasmids 
For Promoter-reporter assays (Luciferase assay) a 6x κB-dependent firefly luciferase 
construct and an ubiquitin-dependent Renilla luciferase construct was used (kindly 
provided by B. Baumann, University of Ulm). Expression vectors for hMD2 and mMD2 
were kindly provided by Dr. M. Muroi, National Institute of Health Sciences, Tokyo, 
Japan [96]. Hemagglutinin (HA)-tagged TLR4 receptor plasmids of mouse and human 
origin were generously provided by A. M. Hajjar, Department of Immunology, University 
of Washington Medical School, Seattle, USA [97]. FLAG-tagged CMV1-TLR4 plasmid 
was purchased from Tularik Inc. (San Francisco, USA). 
 
2.9 siRNAs (double stranded - oligo nucleotides) 
 
The following commercially available siRNAs (Qiagen, Hilden) were used to knock down 
the expression of individual proteins in HUVEC: 
 
siRNA Scr    Negative control siRNA Alexa fluor 488 (# 1022563) 
Target sequence AATTCTCCGAACGTGTCACGT 
siRNA MyD88   Hs_MYD88_5_HP Validated siRNA (# SI00300909) 
     Target sequence AACTGGAACAGACAAACTATC 
siRNA MD2    Hs_LY96_8_HP Validated siRNA (#SI03246446) 
Target sequence AACAATATCATTCTCCTTCAA 
siRNA TLR4    Hs_TLR4_1 (# SI00151004) 
Target sequence CTCGATGATATTATTGACTTA 
 
2.10 Primary cells, cell lines and bacteria 
 
HUVEC Primary human umbilical vein endothelial cell; 
Promocell (Heidelberg) 
 
NHEK Juvenile primary normal human foreskin epidermal 
keratinocytes; Promocell (Heidelberg) 
 
HEK293 Human embryonic kidney epithelial cell line; 
InvivoGen (Toulouse, France) 
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HEK293-hMD2/CD14 HEK293-cell line, stably expressing human MD2 
and CD14; InvivoGen (Toulouse, France) 
 
HEK293-hTLR4 HEK293-cell line, stably expressing human TLR4; 
InvivoGen (Toulouse, France) 
 
HEK293-hTLR4/MD2/CD14 HEK293-cell line, stably expressing human TLR4, 
human MD2 and CD14; InvivoGen (Toulouse, 
France) 
 
THP-1     Human monocytic cell line; DSMZ (Braunschweig) 
 
RAW 264.7    Mouse macrophage cell line; ATCC TIB#71  
(Manassas, USA) 
 
DH5 Heat competent E. coli strain for the amplification 
from recombinant plasmids; Bethesda Research 
Laboratories (Bethesda, USA) 
2.11 General equipments 
Incubator: HERAcell 150     Thermo Fisher (Dreieich) 
Laminar flow hood: HERAsafe    Thermo Fisher (Dreieich) 
Mega centrifuge: megafuge 1.0R    Thermo Fisher (Dreieich) 
Mini centrifuges: MiniSpin plus and 5417R   Eppendorf (Hamburg) 
Microscopes: Leica DM IL and Leica DM IRB  Leica (Solms) 
Balances: Sartorius TE1502S and Sartorius BP301S Sartorius (Göttingen) 
PCR-cycler: Flex cycler Biozym (Oldendorf) 
Electrophoresis chambers (DNA-gels)   Biometra (Göttingen) 
Gel-iX imager       Intas (Göttingen) 
Western blotting chambers (protein gels)   BioRad (Munich) 
Nano drop 2000c      Peqlab (Erlangen) 
Multiplate reader Tecan (Crailsheim) 
X-ray film developing machine    Kodak (Stuttgart) 
FACS Canto Becton Dickinson (Heidelberg) 
RT-PCR: Stratagene MX3005p    Agilent (Böblingen) 
Magnetic stirrers      Heidolph (Schwabach) 
pH meter       Knick (Berlin) 
Bacteria shaker      Edmund Bühler (Hechingen) 
Thermomixer Eppendorf (Hamburg) 
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3 Methods 
 
3.1 Cell culture 
All cell culture work was carried out under sterile conditions (under laminar air flow, using 
sterile solutions and media, sterile consumables). All primary cells and cell lines were 
grown at 37°C, 5% CO2 and high humidity. 
 
3.1.1 Storage, freezing and re-cultivation of cells 
 
Long-term storage of all the cells was carried out in liquid nitrogen. For freezing, the cells 
in the culture dish/flask were washed two times with PBS and incubated with 1 x 
trypsin/EDTA for 5 min. The effect of trypsin was neutralized with an equal volume of 
PBS containing 10% FBS. The cells were centrifuged, pelleted and reconstituted in 1 ml 
of freezing medium composed of 10% DMSO, 10% Fetal Bovine Serum (FBS) and 80% 
of the respective culture medium. The cells were aliquoted in cryotubes and frozen 
overnight at -80°C in a Styrofoam rack. The aliquots were transferred into liquid nitrogen 
after two days. For experimental culture, cell aliquots were thawed from liquid nitrogen 
in a water bath at 37°C, suspended in pre-warmed medium and distributed to culture 
vessels. 
3.1.2 Cell culture methodology 
3.1.2.1 Primary human umbilical vein endothelial cells (HUVECs) 
 
HUVECs were purchased from PromoCell (Heidelberg). The stock aliquots were 
propagated till passage 3, frozen and stored in liquid nitrogen as described above. For 
experiments, HUVECs were seeded as adherent monolayer cells at a density of at least 
4300 cells/cm2 of the cell culture vessels. The medium was changed every 2 days, until 
they reached the desired confluency. 
 
Culture medium: It constituted of a mixture of 1 part of endothelial basal medium (EBM) 
supplemented with EGM SingleQuot Supplements and Growth Factors (500 ml of basal 
medium are supplemented with 10 ml FBS, 0.5 ml of human endothelial growth factor 
(hEGF), 0.5 ml hydrocortisone, 0.5 ml of gentamycin/amphotericin B and 2 ml of bovine 
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brain extract with heparin) and 2 parts of M199 medium with 10% FBS, 30 mg ml-1 
gentamycin, 15 pg ml-1 amphotericin B and 0.8 IU ml-1 heparin.  
3.1.2.2 HEK293, HEK293 hMD2, HEK293 hTLR4 and HEK293 hTLR4/MD2 
 
HEK293 is an experimentally transformed cell line obtained from cultures of human 
embryonic kidney cells sheared with adenovirus 5 DNA. Additionally, HEK cells stably 
expressing transfectants hMD2 (HEK293 MD2) or hTLR4 (HEK293 hTLR4) alone or 
both in combination (HEK293 hTLR4/MD2/CD14) were also obtained from InvivoGen 
(Toulouse, France). All HEK cell lines were held in continuous adherent monolayer 
culture. Parental (WT) HEK293 cells were split 1:8-1:10 and derived cell lines at 1:4 twice 
a week at 70-80% confluence. For this, the cells were gently washed once with PBS and 
then incubated briefly (about 1 min) with 1 x trypsin/EDTA. The trypsin was inactivated 
by the detachment of the cells with an equivalent volume of medium containing 10% FBS. 
The cells were centrifuged for 5 min at 1200 rpm, pelleted and resolved in fresh medium, 
and then seeded in cell culture vessels at a density of at least 4300 cells/cm2.  
Culture medium: DMEM supplemented with 10% FBS, and 30 mg ml-1 gentamycin. 
3.1.2.3 THP-1 
 
The human monocytic suspension cell line THP-1 was cultured according to the protocol 
of DSMZ (Braunschweig, Germany) at a density between 2 x 105 and 1 x 106 cells/ml. 
Therefore, after every 2-3 days the number of cells was determined by Neubauer chamber 
and the cells were split accordingly. For the change of medium or passaging, the cell 
suspension was centrifuged for 5 min at 1200 rpm and then the pellet was resuspended in 
fresh medium. This suspension was seeded at a density of 3.5 x 105 cells/ml for further 
passaging or the day before an experiment at densities of 2 x 105 cells/ml in 24-well plate. 
Culture medium: RPMI1640 supplemented with 10% FBS, 1 x non-essential amino acids, 
1 x penicillin/streptomycin, 1 mM sodium pyruvate and 2 mM glutamine. 
3.1.2.4 NHEK 
 
Primary normal human epidermal keratinocytes (NHEK) isolated from neonatal foreskin 
were purchased from PromoCell (Heidelberg). The stock aliquots were expanded until 
passage 4 and then cells were incubated with EDTA prior trypsinization and frozen in 
liquid nitrogen with chelex treated 10% FCS. Chelex was used here to remove calcium 
from the FCS thereby preventing calcium-induced differentiation of NHEKs upon 
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subculture. For experiments, frozen NHEKs from liquid nitrogen were pre-passaged and 
were seeded as adherent monolayer cells at a density of at least 4300 cells/cm2 of the cell 
culture vessels. The medium was changed every 2 days, until they reached the desired 
confluency. 
Culture medium:  1:1 mixture of serum-free keratinocyte growth medium (Thermo Fisher, 
Darmstadt) containing 50 µg ml-1 bovine pituitary extract (BPE) and 5 ng ml-1 epidermal 
growth factor (EGF) and calcium-free EMEM (without further supplements). The final 
calcium concentration of the mixture medium was 0.05 mM. 
3.1.2.5 RAW 264.7 
 
RAW 264.7 is a mouse macrophage cell line obtained from ATCC (Manassas, USA). The 
cells were in continuous adherent monolayer culture, split 1:5 twice a week at 70-80% 
confluence. Subcultures were prepared by scraping. For this, the cells were washed twice 
with PBS and then scraped gently with a sterile cell scraper. The detached cells were 
resolved with the culture medium and collected in a falcon tube. Further the cells were 
centrifuged for 5 min at 1200 rpm, pelleted and resolved in fresh medium, and then seeded 
in cell culture vessels at a density of at least 2200 cells/cm2.  
Culture medium: DMEM supplemented with 10% FBS, and 30 mg ml-1 gentamycin. 
3.1.2.6 Primary human dendritic cells 
 
Primary human immature dendritic cells (iDCs) were generated from CD14+ monocytes 
isolated from patient blood samples by our collaborators in Freiburg according to an 
earlier published method [98]. The protocol was approved by the Ethics Committee of the 
University Freiburg Medical Center, Freiburg, Germany. Seeding of iDCs were done a 
day before the stimulation experiment. After the respective incubation times, supernatant 
medium was harvested, frozen and transported to Department of Dermatology, 
Venerology and Allergology, Giessen for further analysis. 
 
3.2 Gene transfer methods in eukaryotic cells 
 
Depending on the cell type and purpose of the experiment, different protocols of 
transfection were used. For transient transfection in HUVECs, the DEAE-dextran method 
was employed. For RNAi in HUVECs, oligofectamine transfection method was used. 
HEK293 lines were transfected with the calcium phosphate precipitation or Lipofectamine 
2000. For NHEKs the commercially available transfection reagent FuGENE HD suited as 
21 
 
the best method. For all the methods, cells on the day of transfection were in the 
logarithmic growth phase (about 40-60% confluence). 
 
3.2.1 DEAE-dextran transfection 
 
This method was employed for HUVECs in 10 cm dishes. Cells were washed once with 
HEPES / PBS (1 mM). Then the transfection mix containing 4 ml of HEPES/PBS (1 mM, 
pH 7.4), 100 µl of DEAE-dextran solution (10 mg ml-1) and 4 µg DNA, was added to the 
cells followed by a 30 min incubation step at 37°C and 5% CO2. Further, 6 ml of 
chloroquine solution containing M199 medium supplemented with 10% FBS and 0.15 
mM chloroquine, was added to the cells and incubated for 3 h at 37°C and 5% CO2. After 
the incubation, the medium was aspirated and a fresh 3 ml of serum-free M199 medium 
containing 10% DMSO was added and the cells were kept in a tumbling shaker for 150 
seconds at room temperature. Finally, the medium was completely aspirated and the cells 
were cultured in normal culture medium for further use. 
 
3.2.2 Calcium phosphate transfection 
 
Calcium phosphate transfection of cells in a 10 cm culture dish was performed according 
to a modified protocol of Graham and van der Eb [99]. Cells were seeded in an antibiotic-
free culture medium one day prior to transfection. On the day of transfection, the DNA 
precipitate was prepared in a microcentrifuge tube, containing 12 µg DNA and sterile dd 
H2O (volume adjusted to 450 µl). Then, 50 µl of CaCl2 solution (2.5 M) was added slowly 
with gentle stirring. After vortexing, 500 µl of 2 x HBS was pipetted gently in a circular 
motion from the bottom of the tube to the top without touching the walls of the tube. After 
fully adding the buffer, the mixed solution was taken up and down to mix with bubbles 
through the pipette. Finally, the transfection mix was added drop-wise to the cells in the 
petri dish. The dish was then gently mixed and incubated at 37°C and 5% CO2. On the 
next day, the medium was aspirated and fresh medium was added. 
 
3.2.3 Oligofectamine transfection 
 
HUVECs were transfected with small interfering RNA (siRNA), using oligofectamine 
reagent. HUVECs were seeded in 6-well plates (1.2 x 105 cells/well) a day prior to the 
transfection. On day 2, the transfection mix was prepared as two separate parts namely 
solution A and solution B. Solution A was composed of 10 µl siRNA (20 µM) and 90 µl 
OptiMEM medium and solution B consisting of 6 µl oligofectamine and 94 µl OptiMEM. 
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Both the solutions were first separately incubated for 10 min at room temperature, mixed 
together and allowed to stand for 30 min. Cells were washed twice with OptiMEM during 
the incubation time. Finally, 800 µl of OptiMEM and the entire 200 µl of the mixed 
solutions of A + B were added to the cells followed by an incubation of 4 h at 37°C and 
5% CO2. The final concentration of siRNA in this mix was 200 nM. Normal culture 
medium was freshly added after aspirating the siRNA transfection mix. 
 
3.2.4 Lipofectamine transfection 
 
For co-immunoprecipitation experiments, HEK293 and HEK293 hMD2 cells were seeded 
with antibiotic-free culture medium at a density of 5 x 106 cells per 10 cm culture dish, 
one day prior to transfection. The cells were transiently transfected with 24 µg DNA and 
60 µl of Lipofectamine 2000 according to manufacturer’s suggestions. Medium was 
changed 6 h post transfection and cells were grown in complete culture medium for at 
least 40 h for further analysis. 
 
3.2.5 Fugene HD transfection 
 
NHEK cells were seeded in 6-well culture dishes with antibiotic-free culture medium at a 
density of 1 x 105 cells per well, two days prior to transfection. The cells were transiently 
transfected with 1 µg DNA and 3 µl of FuGENE HD reagent according to manufacturer’s 
description. Medium was changed 6 h post transfection and cells were grown in complete 
culture medium for at least 40 h after which they were utilized for stimulation experiments. 
 
3.3 qRT PCR 
 
Total RNA was isolated by a spin column-based technique using an RNeasy mini kit 
(Qiagen, Hilden). RNA concentration was photometrically determined, and cDNA was 
synthesized from 1 g of total RNA using the high fidelity cDNA synthesis kit (Roche, 
Mannheim). Primers and probes were purchased from Thermo Fisher (Darmstadt) for 
human TLR4 (Hs00152939_m1), human MD2 (Hs00209770_m1), GAPDH 
(Hs99999905_m1) and Loricrin (Hs01894962_s1). qRT-PCR was performed using the 
primer probe method (TaqMan gene expression master mix; catalogue number 4369016, 
Thermo Fisher, Darmstadt) and raw data acquired with Stratagene’s Mx3005P (Agilent, 
Böblingen). Pipetting errors were corrected by passive 5-carboxy-X-rhodamine (ROX) 
fluorescence. Gene expression was normalized to the housekeeping control gene GAPDH, 
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and the relative expression of genes of interest compared to the respective experimental 
control was calculated using the comparative PCR method and MxPro-Mx3005 software 
(version 4.01) from Stratagene (Agilent, Böblingen) as described elsewhere [100]. 
3.4 Cell lysis for protein analysis 
 
For lysis, cells were washed twice with ice-cold PBS in the culture dish and incubated for 
at least 60 min at 4°C with E1A lysis buffer (ELB). After the incubation period the cell 
lysates were scraped from the culture dish by a cell scraper and transferred onto 
microcentrifuge tube. The insoluble cell components were removed by centrifugation at 
14,000 rpm for 10 min at 4°C. The protein content was determined using the standard 
quick start Bradford dye reagent (BioRad, Munich) according to manufacturer's 
instructions. The lysates for western blot were mixed in a ratio of 3:1 with 4 x SDS sample 
buffer, denatured for 5 min at 95°C and stored until use at -20°C. 
 
3.5 Western blot 
3.5.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE separates the proteins on the basis of their molecular weight, with smaller 
polypeptides migrating more rapidly. The SDS-polyacrylamide gels were casted with two 
sequential layers, namely the upper stacking gel and the lower resolving gel. The stacking 
gel is slightly acidic (pH 6.8) and has a low acrylamide concentration to make a porous 
gel. Under these conditions, proteins separate poorly but form thin, sharply defined bands. 
The resolving gel, is more basic (pH 8.8), and has a higher polyacrylamide content, which 
causes the gel to have narrower pores. The acrylamide content of the resolving gel (8% to 
12%) was calculated according to the size of the proteins under investigation. The 
following table contains the pipetting scheme, after which the individual gels were cast. 
The composition of the pre-mixes for resolving gel and stacking gel are described in 
section 2.2.1. 
 
Concentration of the stacking / 
resolving gels 
8% 10% 12% 
30% Acrylamide 2.66 ml 3.33 ml 4 ml 
Resolving gel pre-mix 5 ml 5 ml 5 ml 
Stacking gel pre-mix - - - 
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deionised H2O 2.33 ml 1.66 ml 1 ml 
Ammonium per sulphate (APS) 100 l 100 l 100 l 
Tetra methyl ethylene diamine 
(TEMED) 
4 l 4 l 4 l 
Optimum Separation for > 90 kDa 40-90 kDa < 40 kDa 
 
The polymerized gel was fixed in a vertical apparatus and the reservoir was filled with 
running gel buffer (Section 2.2.1). Then the samples were mixed with SDS sample buffer 
and loaded on separate wells of the stacking gel. At least 30 µg of protein was loaded in 
each well. Electrophoresis was for 50-60 min at a constant current of 40-50 mA using the 
mini-gel system. 
 
3.5.2 Protein transfer 
 
The wet blot method was used for the immunological detection of the separated proteins 
from SDS-PAGE. Based on the advice of the antibody manufacturer, a nitrocellulose 
membrane (Schleicher and Schüll, Dassel) or a methanol-activated polyvinylidene 
fluoride (PVDF) membrane (Immobilon®, Millipore, Schwalbach) was employed for the 
transfer. Proteins having a higher molecular weight (>50 kDa) were blotted for 90 min 
and those less than 50 kDa were blotted for 60 min at a constant current of 400 mA. 
3.5.3 Immuno detection 
To saturate non-specific binding, the membrane after the blot was blocked for 1 h at room 
temperature (RT) in powdered fresh milk blocking buffer (Section 2.2.1). For the detection 
of individual proteins, the membrane was then treated with the appropriate primary 
antibody diluted in fresh milk blocking buffer, incubated at 4°C overnight. After washing 
three times with TBS-T (each 7 min), the incubation was carried out with the respective 
horseradish peroxidase (HRP) coupled secondary antibody for 1 h at RT. The membrane 
was washed again four times with TBS-T for the removal of non-specifically bound 
secondary antibody. The bound HRP-coupled secondary antibodies were detected 
according to the principle of enhanced chemiluminescence (ECL) with ECL western 
blotting detection reagents and X-ray films from GE Healthcare (Munich) according to 
the manufacturer's protocol. Alternatively, self-produced ECL reagent was used 
sometimes (0.1 M Tris-HCl (pH 8.5), 2.5 mM luminol, 0.4 mM para hydroxycoumaric 
acid and 0.02% H2O2 in dd H2O). 
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3.5.4 Stripping 
For a second time use of a blot for antibody incubation, previously bound antibody 
complexes were removed by 30 min incubation at 50°C in stripping buffer (Section 2.2.1). 
Subsequently, the membrane was again incubated with blocking buffer and antibody 
dilutions as described in Section 3.5.3. 
3.6 Enzyme-linked immunosorbent assay (ELISA) 
 
For the detection of IL-8 or TNF in cell culture supernatant, ELISAs were performed. At 
the end of the stimulation period, cell culture supernatant was transferred into a 
microcentrifuge tube, centrifuged at 5000 rpm to remove the cell debris, and stored at  
-20°C until further use. The concentration of IL-8/TNF in these samples was measured 
using the commercially available BD OptEIA human IL-8/TNF ELISA kits (BD 
Pharmingen, Franklin Lakes, USA) according to the manufacturer’s protocol. For this, the 
ELISA microtiter plates were coated overnight with IL-8/TNF detection antibody.  
IL-8/TNF binds to its specific antibodies on the surface of the microtiter plate and detected 
by a detection complex of HRP avidin and IL-8/TNF detection antibody. This detection 
complex was colorimetrically analysed using the ELISA reader and the results were 
quantitatively evaluated by comparing with the internal standard curve series. All the 
samples were analyzed at least in duplicate and the values obtained are shown relative to 
unstimulated controls. 
 
3.7 Promoter-reporter assay (luciferase assay) 
 
For determining the activation of the transcription factor NF-B, HUVEC or HEK293 
cells were transfected in culture dishes using the DEAE-dextran method or calcium 
phosphate method, respectively (sections 3.2.2 and 3.2.3). The DNA of interest along with 
a 6 x B promoter-dependent Firefly luciferase and a ubiquitin promoter-dependent 
Renilla luciferase were transfected in the ratio of 30:1. One day later, cells were washed 
with sterile PBS and detached from the culture dishes with 1 x trypsin-EDTA, and seeded 
in a 96-well flat-bottom microtiter plate at a density of 20,000 cells per well for HUVECs 
and 30,000 cells per well for HEK293 lines. After 24 h, the cells were stimulated for 8 h, 
luciferase activity was measured according to the manufacturer’s suggestions using the 
DualGlo luciferase assay system from (Promega, USA). 6 x B-dependent luciferase 
activities were normalized to the luminescence generated by the Renilla luciferase control 
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reporter and expressed as fold stimulation. All experimental samples were at least 
measured in triplicates. 
 
3.8 Flow cytometry 
 
For the surface expression analysis of HA-tagged hTLR4 and intracellular detection of  
IL-8, flow cytometry was performed as follows. At 48 h after transfection, cells were 
exposed to Ni2+, Co
2+, LPS or medium as control for 8 h. We added 0.2 μg ml-1 brefeldin 
A in order to avoid secretion of the chemokine via the Golgi pathway. Cells were 
subsequently harvested, washed, fixed with 4% paraformaldehyde in PBS at 4°C for 20 
min, and then co-incubated with different combinations of monoclonal antibodies against 
HA/IL-8 or the corresponding isotype control monoclonal antibodies that had been diluted 
in permeabilization buffer containing 1% fetal calf serum, 0.1% saponin, and PBS. 
Thereafter, cells were successively stained with FITC-coupled anti-rat secondary antibody 
or Cy5-coupled anti-mouse detection antibody. Fluorescence was determined with a 
FACSCanto II (Becton Dickinson, Heidelberg), which is a four-color, dual-laser, 
benchtop system capable of both cell analysis and sorting. Readout molecules were then 
analyzed after gating on the HA-positive population. Non-viable cells were excluded by 
means of forward scatter and side scatter parameters. 
 
3.9 Immunoprecipitation 
 
HEK293 WT cells and HEK293 hMD2 cells transiently expressing the different FLAG- 
or HA-tagged hTLR4 proteins were lysed in E1A lysis buffer as detailed earlier. Total 
protein (1.5 g) was then subjected to immunoprecipitation with mouse anti-FLAG 
monoclonal antibody for overnight and protein-G-agarose (Roche, Mannheim) for 1 h. 
After the incubation, samples were washed with high salt E1A lysis buffer containing 500 
mM sodium chloride for three times. The immunoprecipitates were then boiled in SDS 
loading buffer, resolved on SDS-PAGE and transferred to polyvinylidene difluoride or 
nitrocellulose membranes. The membrane then was subjected to western blots using -
HA or -FLAG antibodies as detailed in section 3.5. 
 
3.10 Site directed mutagenesis 
 
For replacement of the codons (single and double point mutations) in hTLR4 and mTLR4, 
site-directed mutagenesis was performed using Quick-change II site directed mutagenesis 
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kit® (Stratagene-Agilent, Böblingen) according to the manufacturer’s suggestions using 
TLR4 complementary primers containing single nucleotide mismatches at the target 
codon sequence. Following primers were used for the single mutants: 
Mutant Primers 
hTLR4 
H431A 
Forward 
5’CAACTAGAACATCTGGATTTCCAGGCTTCCAATTTGAAACAAATGAGTGA3’ 
Reverse 
5’TCACTCATTTGTTTCAAATTGGAAGCCTGGAAATCCAGATGTTCTAGTTG3’ 
hTLR4 
N433A 
Forward 
5’GAACATCTGGATTTCCAGCATTCCGCTTTGAAACAAATGAGTGAGTTTTC3’ 
Reverse 
5’GAAAACTCACTCATTTGTTTCAAAGCGGAATGCTGGAAATCCAGATGTTC3’ 
hTLR4 
H456A 
Forward 
5’CCTCATTTACCTTGACATTTCTGCTACTCACACCAGAGTTGCTTTC3’ 
Reverse 
5’GAAAGCAACTCTGGTGTGAGTAGCAGAAATGTCAAGGTAAATGAGG3’ 
hTLR4 
H458A 
Forward 
5’CATTTACCTTGACATTTCTCATACTGCCACCAGAGTTGCTTTCAATG3’ 
Reverse 
5’CATTGAAAGCAACTCTGGTGGCAGTATGAGAAATGTCAAGGTAAATG3’ 
mTLR4 
Y454H 
Forward 
5’AGCTACTTTACCTTGACATCTCTCATACTAACACCAAAATTGACTTC3’ 
Reverse 
5’GAAGTCAATTTTGGTGTTAGTATGAGAGATGTCAAGGTAAAGTAGCT3’ 
mTLR4 
N456H 
Forward 
5’AAAGCTACTTTACCTTGACATCTCTTATACTCACACCAAAATTGACTT3’ 
Reverse 
5’AAGTCAATTTTGGTGTGAGTATAAGAGATGTCAAGGTAAAGTAGCTTT3’ 
 
The hTLR4 double mutant was produced by introducing a H456A replacement in the HA-
hTLR4-H458A construct using the following primer set: 
 
Mutant Primers 
hTLR4-
H456A/ 
H458A 
Forward 
5’CCTCATTTACCTTGACATTTCTGCTACTGCCACCAGAGTTGCTT3’ 
Reverse 
5’AAGCAACTCTGGTGGCAGTAGCAGAAATGTCAAGGTAAATGAGG3’ 
 
The mTLR4 double mutant was produced by introducing an Y454H replacement in the 
HA-mTLR4-N456H construct using the following primers: 
 
Mutant Primers 
mTLR4-
Y454H/ 
N456H 
Forward 
5’AGCTACTTTACCTTGACATCTCTCATACTCACACCAAAATTGACT3’ 
Reverse 
5’AGTCAATTTTGGTGTGAGTATGAGAGATGTCAAGGTAAAGTAGCT3’ 
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The soluble form of the hTLR4 (sTLR4) comprises the extracellular domain of native 
TLR4 (aa 27-628) lacking the N-terminus that encodes its signal sequence. Instead, the 
respective N-terminal region was replaced by N-terminal in-frame fusion to the signal 
peptide of the Ig chain leader sequence to allow secretion in the absence of MD2. sTLR4 
cDNA was constructed from pDisplay-HA-hTLR4 [97] by stop codon insertion at position 
Q628 using site-directed mutagenesis using the primers listed below: 
 
Mutant Primers 
hTLR4-
Q628* 
(sTLR4) 
Forward 
5’GTGCTGAGTTTGAATATCACCTGTTAGATGAATAAGACCATCATTG3’ 
Reverse 
5’CAATGATGGTCTTATTCATCTAACAGGTGATATTCAAACTCAGCAC3’ 
 
All the mutant cDNAs were sequenced to confirm the mutations. 
 
3.11 qRT PCR array 
 
Isolated total RNA (0.1 - 1 g) was reverse transcribed using RT2 First Strand Kit (Qiagen, 
Hilden) to obtain cDNA and internal controls. cDNA was then used to simultaneously 
monitor mRNA expression of 84 different human cytokine and cytokine receptor genes 
per sample by SYBR-green based qRT-PCR using the RT² Profiler™ PCR Array System 
(Array PAHS-022, Qiagen, Hilden). Experiments were performed according to the 
manufacturer’s protocol using the suggested reagents. To allow statistical evaluation, 
average fold-induction and p-values from four independent experiments were calculated 
using an analysis template provided by the manufacturer. Data were each normalized to 
the expression of 4 different housekeeping genes run on the same 96-well plate. Only 
genes showing a mean regulation of at least 2.5-fold and a p-value <0.05 were considered 
to be significantly regulated. Genomic DNA contamination potentially masking reliable 
gene regulation was controlled for using a specific probe run in parallel. Gene-specific 
primers consistently delivering multiple PCR products or low Tm values as determined by 
melting curve analysis were excluded from the analysis to avoid false positives due to 
unspecific amplification or primer dimers, respectively. 
 
3.12 Molecular biology techniques 
 
Standard molecular biology methods were carried out as described by Sambrook et al. 
[95]. 
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3.12.1 Transformation of plasmid DNA in bacteria 
 
Transformation was performed by integrating the plasmid DNA into competent DH5-
bacteria using heat shock method, according to Sambrook et al. [95]. The transformed 
bacteria were plated for selection of plasmid-colonies with ampicillin resistance on 
Lysogeny Broth (LB) agar plates containing 50 µg ml-1 ampicillin. Single colonies were 
picked from overnight cultures and were expanded in LB medium with 50 µg ml-1 
ampicillin. 
 
3.12.2 Mini, midi and maxi preparation of plasmid DNA 
 
Plasmid DNA preparations from the overnight cultures were purified using anion 
exchange columns from the Qiagen plasmid purification kits according to the 
manufacturer’s protocol. At the end of the purification steps, the precipitated DNA was 
pelleted and adequate volume of dd H2O was added depending on the size of the pellet 
(200 to 500 µl). The DNA concentration was measured photometrically determining 
absorbance at 260 nm using a Nanodrop 2000c system (Peqlab, Erlangen). The plasmid 
DNA was stored at -20°C for further usage. 
 
3.12.3 Sequencing  
 
Sequencing was performed using the BigDye terminator cycle sequencing kit from 
Thermo Fisher (Darmstadt) and carried out according to the method of Sanger [101]. 
Instead of radio-labeled Didesoxynucleosidetriphosphate (ddNTPs) distinct fluorescent 
ddNTPs were used. Mini preparation DNA was used as templates for the sequencing. The 
amount of DNA used was 50-100 ng and the primer concentration was 2 pmol µl-1. All 
other reagents were used as recommended in the manufacturer's instructions. 
Alternatively, a commercial sequencing service from MWG-Eurofins (Munich) was used 
and samples processed according to the guidelines of the service company. 
3.12.4 Restriction digestion, separation of DNA fragments by agarose gel 
electrophoresis 
 
This method makes use of the property of restriction endonucleases to recognize and cut 
a specific and short sequence of DNA. For control of the successful preparation of plasmid 
DNA, 5 µl of the DNA solution was digested with 0.5 µl (corresponding to 5 Units) of 
two different appropriate restriction enzymes in 2 µl of 10 x buffer solution and 14 µl dd 
H2O. Digestion reaction was performed for 1 to 2 h at 37°C.  Preferentially, enzymes were 
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chosen that they cut out the insert from the plasmid DNA, so that a characteristic 
identification of the DNA fragment is created. Depending on the length of the expected 
fragments, gels were casted with an agarose concentration ranging from 0.8% to 1.5%. 
The agarose was dissolved completely by boiling briefly in an appropriate volume of 1 × 
TAE buffer. After cooling the solution to 50-60°C, the solution was mixed with  
1 mg ml-1 ethidium bromide (about 1 µl/100 ml) and poured onto a gel compartment with 
comb for proper wells. The solidified gel was completely covered with TAE buffer in the 
electrophoresis chamber. The samples and a DNA molecular weight marker were 
dissolved in 6 x bromophenol blue sample buffer (see Section 2.2.1) and the mixture was 
transferred into the respective wells. After electrophoretic separation in an agarose gel, 
the DNA fragments were detected by UV light ( = 312 nm) using the fluorescent 
intercalated ethidium bromide. 
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4 Results 
 
4.1 Ni2+ activates NF-B pathway 
 
Previous studies from our laboratory have shown that the contact allergen Ni2+ is capable 
of directly targeting proinflammatory intracellular signal transduction cascades resulting 
in the activation of transcription factor NF-κB (Fig. 1) and the mitogen-activated protein 
(MAP) kinase p38 [57, 66, 102]. However, the molecular mechanisms underlying 
generation of the proinflammatory signal at that time were unknown. Subsequent gene 
profiling studies revealed that Ni2+ elicits an expression pattern reminiscent of innate 
immune signals, which is dominated by proinflammatory genes [59].  
 
The initiation of such signals relies on membrane-bound and intracellular receptors known 
as PRRs. The best known classes are the TLR family, which primarily senses microbial 
pathogens, and the NOD-like receptors that not only detect microbes but also inorganic 
agents such as crystalline urates, asbestos, silica and aluminium [3] [103] [104].  
 
 
Fig. 1: Activation of NF-B by the contact allergen Ni2+. Fold average luciferase activation of a 6B 
luciferase (luc) reporter transfected into HUVEC. Cells were stimulated for 16 h with Ni2+ (1.5 mM), TNF 
(2 ng ml-1) or medium as control (Ctrl). Data represent mean ± S.D of three independent experiments.  
** p < 0.01, *** p <0.001 (unpaired t-test). 
 
 
From the preliminary data, it was clear that one of the TLRs was likely to mediate the 
response to Ni2+. It is well known that MyD88 is a general adaptor molecule for the 
Toll/IL-1R family of receptors and HUVECs display unique TLR4 surface expression, but 
lack functional expression of other surface TLRs [105].  
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Therefore, we evaluated the dependency of MyD88 by post transcriptional gene silencing. 
RNA interference (RNAi) of endogenous MyD88 abolished the Ni2+-induced expression 
of IL-8 in ECs (Fig. 2). In agreement with published data [106], the response to IL-1 was 
blocked as well while TNF-dependent IL-8 expression was unaltered. These data 
indicate that Ni2+ induces NF-B-dependent gene expression via MyD88. 
 
 
 
Fig. 2: Immunoblot of IL-8 expression upon stimulation with medium (Ctrl), Ni2+ (1.5 mM), IL-1 (10 U 
ml-1) or TNF (2 ng ml-1) in HUVEC transfected with siRNA for MyD88 or a scrambled siRNA control (Scr). 
Immunoblots are representative of three independent experiments.  
 
 
We examined the involvement of TLR4 in the Ni2+-induced response after excluding 
autocrine stimulation by IL-1 [66]. LPS, the natural ligand of TLR4 and potent 
proinflammatory activator, induced IL-8 to a similar extent as Ni2+ in ECs (Fig. 3). 
 
         
 
Fig. 3: IL-8 production determined by ELISA of supernatants (left) or immunoblot of cell lysates (right) in 
HUVEC stimulated with medium (ctrl), Ni2+ (1.5 mM) or the TLR4 agonist LPS (E. coli 026:B6;  
1 µg ml-1). Bar diagrams (left) represent average values of three independent experiments ± s.d. 
Immunoblots (right) are representative of three independent experiments. *p < 0.05, *** p <0.001, unpaired 
t-test. 
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4.2 Ni2+/Co2+-induced TLR4 activation requires MD2 
 
 
 
Fig. 4: Analysis of IL-8 production by ELISA from HUVEC transfected with siRNAs against MD2 or 
hTLR4 for 48 h prior to stimulation. Cells were then stimulated for 8 h with medium (ctrl), LPS  
(S. minnesota R595; 1 g ml-1), Ni2+ (1.5 mM) or Co2+ (1.5 mM), respectively. Bar diagrams represent 
average values of three independent experiments ± S.D. * p < 0.05, ** p < 0.01, *** p <0.001 (unpaired t-
test). 
 
To unequivocally confirm that TLR4/MD2 expression was responsible for the observed 
innate immune activation by Ni2+/Co2+, we employed small interfering RNA (siRNA). 
Depletion of either TLR4 or MD2 significantly decreased LPS-, Ni2+- and Co2+-induced 
IL-8 production in ECs (Fig. 4). 
 
Fig. 5: Analysis of Ni2+/Co2+-induced IL-8 protein expression in the indicated cell lines as determined by 
western blot analysis of total lysates. Cells were stimulated for 8 h with medium (ctrl), Ni2+ (1.5 mM), Co2+ 
(1.5 mM) or LPS (E. coli 026:B6; 1 µg ml-1) as positive control, respectively. The immunoblot is 
representative of three independent experiments. 
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Supplementation experiments in human HEK293 cells, which lack endogenous TLR4 and 
MD2 expression [107] confirmed a requirement of both receptor components for 
Ni2+/Co2+-induced NF-B activation and proinflammatory gene expression (Fig. 5-7). 
 
 
Fig. 6: Average fold luciferase activation of a 6κB luciferase (luc) reporter transfected into HEK293 WT, 
HEK293 cells stably expressing human MD2 (HEK293-hMD2), hTLR4 (HEK293-hTLR4) or hTLR4 and 
hMD2 (HEK293-hTLR4/hMD2), respectively. HEK cell lines were stimulated for 8 h with medium (ctrl), 
LPS (S. minnesota R595; 1 g ml-1), Ni2+ (1.5 mM) or Co2+ (1.5 mM) respectively. Data represent mean 
values of three independent experiments ± S.D. *** p <0.001 (unpaired t-test). 
 
 
Fig. 7: Analysis of Ni2+/Co2+-induced IL-8 protein expression in the indicated cell lines as determined by 
ELISA of supernatants. Cells were stimulated for 8 h with medium (ctrl), LPS (S. minnesota R595;  
1 g ml-1), Ni2+ (1.5 mM) or Co2+ (1.5 mM), respectively. Bar diagrams represent mean values of three 
independent experiments ± S.D. ** p <0.01, *** p <0.001 (unpaired t-test). 
 
 
The response to Ni2+/Co2+ was not due to LPS contamination since treatment with the 
LPS-inactivating drug polymyxin B sulphate failed to block activation by Ni2+/Co2+ (Fig. 
8). Together, these data show that Ni2+/Co2+-induced proinflammatory gene expression is 
independent of LPS but requires both hTLR4 and hMD2. 
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Fig. 8: Quantification of IL-8 in the supernatants of HEK293-hTLR4/hMD2 cells upon 8 h stimulation with 
medium (Ctrl), LPS (E. coli 055:B5; 1 µg ml-1), Ni2+ (1.5 mM) or Co2+ (1.5 mM) in the absence or presence 
of polymyxin B sulphate (50 mg ml-1). Data represent average values ± s.d. of three independent 
experiments. *** p < 0.001, NS, not significant (unpaired t-test). 
 
 
4.3 Co2+ induces expression of multiple proinflammatory genes in primary ECs 
similar to that of Ni2+ 
 
To understand more about the proinflammatory signaling cascades driven by Co2+, we 
employed a quantitative real time PCR- (qRT-PCR-) based array system to study the RNA 
profiles of 84 human cytokine genes and receptors in primary human ECs. To evade the 
resultant consequences, we treated exponentially growing HUVECs for only a short time 
period (5 h) with 1.5 mM CoCl2 and subjected RNA extractions from those samples to the 
qRT-PCR array. Material from four different experiments were analyzed in parallel to 
guarantee a high statistical significance.  
 
Table 1 lists the proinflammatory genes that were significantly activated by Co2+. These 
comprised of genes that were  regulated by NF-B such as CXCL3 (Gro-γ) or CCL20 
(MIP3-α) [108] in addition to genes such as CXCL-10 (IP-10), which rather specify a 
type-I interferon response [109]. A comparison of the Co2+-induced proinflammatory 
genes to those found in an earlier gene-chip microarray study of Ni2+-regulated transcripts 
[59] showed a remarkable similarity of target genes by both stimuli, demonstrating a 
comparable style of action by both metal haptens. 
 
A Upregulated genes 
Gene Symbol Description 
Fold 
up 
by Co2+ 
p-value 
Regulation 
by Ni2+ 
CXCL3 (Gro-γ) Chemokine (C-X-C motif) ligand 3 36.28 0.042799 On 
CCL20 (MIP3-α) Chemokine (C-C motif) ligand 20 23.32 0.011699 On 
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CXCL2 (Gro-β) Chemokine (C-X-C motif) ligand 2 14.84 0.048677 35.97 
CXCL6 (GCP2) Chemokine (C-X-C motif) ligand 6 
(granulocyte chemotactic protein 2) 
14.28 0.000209 21.68 
CCL5 (RANTES) Chemokine (C-C motif) ligand 5 13.40 0.033357 No 
IL-8 Interleukin-8 11.72 4.47E-08 32.95 
CXCL1 (Gro-a) Chemokine (C-X-C motif) ligand 1 
(melanoma growth stimulating activity, 
alpha) 
8.01 0.002375 23.70 
CXCL5 (ENA 78) Chemokine (C-X-C motif) ligand 5 7.36 0.020081 12.75 
LTB (TNFC) Lymphotoxin beta (TNF C) 6.46 1.06E-07 On 
IL1A Interleukin 1, alpha 5.72 0.006050 On 
TNF (TNF-α) Tumor necrosis factor alpha 5.47 0.010384 No 
CEBPB (NF-IL6) CCAAT/enhancer binding protein, beta 5.18 0.010484 4.27 
LTA (TNFB) Lymphotoxin alpha (TNF ß) 3.63 0.000125 On 
CXCL10 (IP-10) Chemokine (C-X-C motif) ligand 10 3.40 0.009645 On 
 
B Downregulated genes 
Gene Symbol Description 
Fold 
down 
by Co2+ 
p-value 
Regulation 
by Ni2+ 
CXCL12 (SDF1) Chemokine (C-X-C motif) ligand 12 
(stromal cell-derived factor 1) 
-17.71 0.005603 No 
AIMP1 (SCYE1) Aminoacyl tRNA synthetase complex-
interacting multifunctional protein 
1/Small inducible cytokine subfamily E, 
member 1  
-3.49 0.001465 -2.85 
IL10RB Interleukin 10 receptor, beta -2.67 0.000044 No 
 
 
Table 1: RNA isolated from HUVECs stimulated with Co2+ (1.5 mM) or medium as control for 5 h was 
used for qRT-PCR SYBR green array where the expression of 84 genes encoding cytokines and cytokine 
receptors was evaluated. Genes listed here correspond to the transcripts indicating at least a 2.5-fold mean 
up- or down-regulation by Co2+ in comparison to the unstimulated controls. Stringent evaluation of the genes 
with a unique amplification plot assessed by melt curve analysis and statistical significance (p-values < 0.05) 
from four individual experiments were deemed fit for the data analysis. A previously published Ni2+-
responsive genes identified in HUVEC [59] was utilized for co-regulation comparison. 
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4.4 Distinct skin cell types show divergent proinflammatory responsiveness to 
Ni2+/Co2+ 
 
 
Fig. 9: Quantification of IL-8 levels in the culture supernatants of juvenile primary normal human epidermal 
keratinocytes (NHEK). Cells were stimulated for 8 h with Co2+ (1.5 mM), Ni2+ (1.5 mM) or medium as 
control (Ctrl). Bar diagrams represent average values of three independent experiments ± S.D. 
 
 
Fig. 10: Ni2+/Co2+-induced production of the NF-B-dependent cytokine IL-8 as determined by ELISA of 
supernatants from HUVECs endogenously positive for hTLR4/MD2. Cells were stimulated for 8 h with 
Co2+ (1.5 mM), Ni2+ (1.5 mM) or medium as control (Ctrl). Bar diagrams represent average values of three 
independent experiments ± S.D. ** p < 0.01, *** p <0.001 (unpaired t-test). 
 
 
Fig. 11: Ni2+/Co2+ induced IL-8 release from human immature DCs (iDCs). Cells were stimulated for 8 h 
with Co2+ (1.5 mM), Ni2+ (1.5 mM) or medium as control (Ctrl). Bar diagrams represent average ± S.D. 
values from three different donors.  ** p < 0.01, *** p <0.001 (unpaired t-test). 
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Innate immune activation of resident skin cells is the crucial step necessary for the clonal 
proliferation of hapten-specific T cells [110]. Therefore, it is essential to determine and 
compare the responsiveness of various primary human cell types of the skin towards Ni2+ 
and Co2+. Other than DCs that are critically needed for the production of hapten-specific 
T cells, we also assessed keratinocytes which are not only the major cell type found in the 
epidermis but also the early responders of metal allergies in vivo [57, 78, 102]. Moreover, 
keratinocytes lend a big hand in the deployment of leukocytes into the endangered 
epidermal area upon re-exposure to the same allergen [111]. Surprisingly, we observed 
that both Ni2+ and Co2+ failed to trigger IL-8 synthesis in NHEKs only (Fig. 9) but not in 
primary human ECs and iDCs (Fig. 10, 11). From these results, it is clear that 
keratinocytes have an identifiable deficiency in perceiving signals from Ni2+ and Co2+ 
while, other skin cells do not share this trait. 
 
4.5 Failure of keratinocytes to induce proinflammatory responses to Ni2+/Co2+ is 
due to lack of TLR4 
 
 
Fig. 12: IL-8 protein measurement in the supernatants of NHEK stimulated for 8 h with LPS (S. minnesota 
R595; 1 g ml-1), IL-1β (100 U ml-1), TNF (10 ng ml-1) or medium as control (Ctrl). Bar diagrams represent 
average values of three independent experiments ± S.D. 
 
To evaluate if the failure of primary human keratinocytes may result from defective 
hTLR4 function, we stimulated NHEK with LPS, the native ligand for hTLR4 [112]. 
NHEK could not also upregulate the LPS driven IL-8 synthesis due to its failure in 
triggering hTLR4 activation (Fig. 12). However, they induced IL-8 upon stimulation with 
IL-1β or TNF, demonstrating that their insensitivity to hTLR4 stimulation was not due to 
a defect in the IKK2/NF-B module or inability of those cells to produce IL-8 (Fig. 12). 
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Fig. 13: qRT-PCR analysis of hMD2 (black bars) and hTLR4 (grey bars) mRNA expression in NHEK as 
compared to hTLR4/hMD2-negative HEK293 cells or hTLR4/hMD2-positive HUVEC. RNA was isolated 
from unstimulated cells and cDNA was subjected to qRT-PCR analysis using specific Taq-Man probes. 
Gene expression was each normalized to GAPDH expression. Data are presented as average-fold regulation 
± S.D. as compared to the relative expression in HUVEC (arbitrarily set to 100%). Bar diagrams represent 
average values of three independent experiments ± S.D. *** p <0.001 (unpaired t-test). 
 
Subsequent qRT-PCR experiments revealed that keratinocytes lacked detectable mRNA 
expression of hTLR4 but expressed low levels of the co-receptor MD2 (Fig. 13). Both 
CaCl2 induced keratinocyte differentiation (Fig. 14 a) [113] verified by upregulation of 
differentiation marker loricrin (Fig. 14 b) as well as provoking with different 
proinflammatory stimuli including Co2+ or Ni2+ themselves was not able to upregulate 
hTLR4 mRNA expression above detectable limits  (Fig. 15). 
 
 
 
Fig. 14 a: Keratinocytes fail to induce TLR4 expression during differentiation. qRT-PCR analysis of TLR4 
mRNA expression in NHEK as compared to TLR4/MD2-positive HUVEC. RNA was isolated from calcium 
differentiated NHEKs (1.0 mM CaCl2 for the indicated times). After reverse transcription, cDNA was 
subjected to qRT-PCR analysis using specific Taq-Man probes. Gene expression was each normalized to 
GAPDH expression. Data are presented as average-fold regulation ± S.D. as compared to the relative 
expression in HUVEC (arbitrarily set to 100%). Bar diagrams represent average values of three independent 
experiments ± S.D. 
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Fig 14 b: Differentiation was verified by increased mRNA expression of the differentiation marker loricrin. 
Data are presented as average-fold regulation ± S.D. as compared to the relative expression in HUVEC 
(arbitrarily set to 1). Data represents at least three independent experiments.  
 
Fig. 15: Keratinocytes fail to induce TLR4 expression upon proinflammatory activation. qRT-PCR analysis 
of TLR4 mRNA expression in NHEK treated with the indicated proinflammatory stimuli for 16 h. After 
reverse transcription, cDNA was subjected to qRT-PCR analysis using specific Taq-Man probes. Gene 
expression was each normalized to GAPDH expression. Data are presented as average-fold regulation ± 
S.D. as compared to the relative expression in HUVEC (arbitrarily set to 100%). Data represent at least three 
independent experiments. 
 
 
Fig. 16: ELISA data showing IL-8 production in supernatants of NHEK transfected with hMD2, hTLR4, or 
both in combination. Cells were stimulated for 8 h with medium (ctrl), LPS (S. minnesota R595; 1 g ml-1), 
Ni2+ (1.5 mM) or Co2+ (1.5 mM), respectively. Bar diagrams represent average values of three independent 
experiments ± S.D. * p < 0.05, ** p < 0.01, *** p <0.001, NS - not significant (unpaired t-test). 
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This suggests that lack of hTLR4 expression is not a specific feature of undifferentiated 
or non-activated keratinocytes. Transfection of hTLR4 alone without MD2 was adequate 
to impart sensitivity to Ni2+ and Co2+ in these cells (Fig. 16) indicating that the absence of 
hTLR4 accounts for the non-reactivity of keratinocytes to these metal allergens. 
 
4.6 Ni2+/Co2+ activates hTLR4, but not mTLR4 
 
Next, we evaluated whether Ni2+/Co2+ could trigger proinflammatory gene expression in 
other cell types. Human monocytic cell line THP-1 (Fig. 17) significantly up-regulated 
IL-8, which is a direct target gene of NF-B upon Ni2+/Co2+ stimulation. Interestingly, 
mouse-derived cells like bEND2 and Raw 264.7 macrophages (Fig. 18) did not synthesise 
TNF upon Ni2+/Co2+ stimulation. However, LPS stimulation resulted in a significant 
upregulation of TNF (Fig. 18) indicating that the failure of murine cells to Ni2+/Co2+ was 
not due to the absence of TLR4 or MD2.  
 
 
Fig. 17: Ni2+/Co2+-dependent production of IL-8 in the human monocytic cell line THP-1. Cells were 
stimulated for 8 h with medium (ctrl), LPS (E. coli 055:B5; 1 µg ml-1), Ni2+ (1.5 mM) or Co2+ (1.5 mM), 
respectively. Bar diagrams represent average values of three independent experiments ± S.D. *** p <0.001, 
(unpaired t-test). 
 
 
Fig. 18: Failure of Ni2+/Co2+ to induce the NF-B target TNF in the mouse macrophage cell line  
(RAW 264.7). Cells were each stimulated for 8 h with medium (ctrl), Co2+ (1.5 mM), Ni2+ (1.5 mM) or LPS 
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(S. minnesota R595; 1 µg ml-1). Data represent averages of three independent experiments ± s.d.  
*** p < 0.001, NS, not significant (unpaired t-test). 
 
 
 
Fig. 19: Activation of a 6B-luciferase reporter from hTLR4 expressing HEK293 cells transfected with 
hMD2, mMD2 or empty vector and stimulated with medium (ctrl), Co2+ (1.5 mM), Ni2+ (1.5 mM) or LPS 
(S. minnesota R595; 1 µg ml-1). Data represent averages of three independent experiments ± s.d. ** p < 0.01, 
NS, not significant (unpaired t-test). 
 
Further, HEK293 cells stably expressing hTLR4 were transfected with either hMD2 or 
mMD2 to test if the NF-B activation by Ni2+/Co2+ was due to species-specific differences 
in MD2. To our surprise the signals mediated by Ni2+/Co2+ were perceived by hTLR4 (Fig. 
19, 20) regardless of the source of the transfected MD2, indicating that the species 
specificity is conferred by TLR4. 
 
 
Fig. 20: IL-8 release determined by ELISA of supernatants from hTLR4 expressing HEK293 cells 
transfected with hMD2, mMD2 or empty vector and stimulated with medium (ctrl), Co2+ (1.5 mM), Ni2+ 
(1.5 mM) or LPS (S. minnesota R595; 1 µg ml-1). Data represent averages of three independent experiments 
± s.d. ** p < 0.01, NS, not significant (unpaired t-test). 
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4.7 Ni2+-induced gene expression requires sequence motifs present in hTLR4 but 
not in mTLR4 
 
 
Fig. 21: ELISA of IL-8 release (− indicates < 2-fold increase; + indicates ≥ 2-fold increase) in HEK293 
hMD2 cells and transfected with HA-hTLR4, HA-mTLR4 or the indicated chimeric HA-TLR4 constructs. 
Cells were exposed to medium (Ctrl), Ni2+ (1.5 mM) or LPS (S. minnesota R595; 1 µg ml-1) for 8 h. Data 
are representative of four independent experiments. Human sequence parts are shown in green and mouse 
parts in blue colour. 
 
 
Fig. 22: Flow cytometry of intracellular IL-8 protein expressed by positively transfected cell population. 
Stable HEK293 hMD2 cells were transfected with HA-hTLR4, HA-mTLR4 or the indicated chimeric HA-
TLR4 constructs and exposed to Ni2+ (1.5 mM) or LPS (S. minnesota R595; 1 µg ml-1) for 8 h. Transfection 
efficiency was monitored by HA-immunostaining and gating on the HA-positive population. Histogram 
overlays of IL-8 staining (black lines) and isotype-staining (grey lines) representative of three independent 
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experiments are provided. Numbers denote the percentage of IL-8 expressing cells in the HA-gated 
population. 
 
 
Fig. 23: The failure of mTLR4 to respond to Ni2+ is not due to inefficient expression. Flow cytometry 
analysis of intracellular IL-8 and HA staining in hMD2-expressing HEK293 cells transfected with HA-
hTLR4 or HA-mTLR4 after treatment with Ni2+ (1.5 mM) for 8 h. The indicated cell population in the dot 
blots represents the successfully transfected HA-positive live cell population (HA+), used as gate for the  
IL-8 quantifications (histograms). Histograms are identical to those presented in Fig. 22. Percentages of 
total HA positivity in the live population and of IL-8 positivity in the gated HA+ population are indicated. 
Data are representative of three independent experiments.   
 
The difference in responsiveness to Ni2+/Co2+ between hTLR4 and mTLR4 triggered our 
curiosity. Therefore, either HA-tagged wild type constructs for hTLR4 or mTLR4 were 
transfected into HEK293 cells stably expressing hMD2, in addition to HA-tagged 
chimeric TLR4 with unique single or multiple residue alterations of hTLR4 and mTLR4 
[97]. Initially we stimulated transfected cells with Ni2+ or LPS. These experiments showed 
that cells expressing hTLR4-hMD2 gave a very strong response to Ni2+, whereas those 
with mTLR4-hMD2 could not prompt IL-8 synthesis upon Ni2+ exposure (Fig. 21, 22). 
Moreover, we got clear evidences that the amino acid sequence from 369 to 616 of the 
hTLR4 is critically necessary for the activation of NF-κB-dependent gene expression by 
Ni2+ (Fig. 21, 22). These differences did not arise due to non-responsive constructs or 
different levels of expression, which was controlled by co-staining with a specific HA-
tagged antibody (Fig. 23). 
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4.8 Histidine residues mediate Ni2+ responsiveness 
 
 
 
 
Fig. 24: Protein sequence alignment of hTLR4 and mTLR4 between aa 371-604 covering the leucine-rich 
repeats (LRR) 14-22 located in the C-terminal domain of the TLR4  sheet [92]. Conserved histidine 
residues (H) are shown underlined and in red colour bold letters, non-conserved histidines are indicated by 
boxed green colour. 
 
Using protein sequence alignment, amino acid variations of hTLR4 and mTLR4 in the  
N-terminal leucine-rich repeats (LRR) 14 to 22 were determined (Fig. 24). The non-
conserved histidine (H) residues at 456, 458 and 555 in the hTLR4 sequence caught our 
attention due to the fact that histidine-tagged proteins can be purified by nickel/cobalt 
columns. We hypothesized that the non-conserved histidines may be vital for the 
responsiveness to Ni2+ signals. From the crystal structure of hTLR4-hMD2 [92], we could 
easily identify that the two non-conserved histidines at 456 and 458 are very close to the 
conserved histidine residue at 431. In a heterodimer confirmation, these residues are 
postulated to form a cluster of six histidine moieties at the base of the two-fold symmetry 
axis of the hTLR4 monomers (Fig. 25). This layout revealed various prospective cross-
linking binding sites for Ni2+. Additionally, biophysical analysis of the putative metal 
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binding interface showed that the imidazole groups of H456 and H458 are predominantly 
in optimal interval for Ni2+ interaction, but the ones from H431 are far-off (Fig. 25). 
 
 
 
Fig. 25: Model of the potential double metal-binding site in hTLR4 showing a close-up view from the top 
along the two-fold symmetry axis. The model is based on the crystal structure of the hTLR4-hMD2 complex 
(PDB entry 3FXI) with LPS omitted. The side chains of the histidine residues H431, H456 and H458 (sticks 
with nitrogen colored blue) were repositioned with appropriate side chain rotamers, followed by addition of 
Ni2+ ions (green spheres) to yield a pair of metal-binding sites with a geometry similar to that seen in an 
engineered serine protease/inhibitor complex (PDB entry 1SLW) [114]. 
 
 
 
 
Fig. 26: Luciferase activity of a 6b-luc reporter transfected into HEK293 cells stably expressing hMD2 
and the indicated TLR4 constructs. Cells were stimulated for 8 h with medium (Ctrl), Ni2+ (1.5 mM) or LPS 
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(S. minnesota R595; 1 µg ml-1). Luciferase activity is presented as fold stimulation (top) or as Ni2+ 
stimulation in relation to LPS (arbitrarily set to 1, bottom), respectively. Data represents mean ± s.d. of three 
independent experiments. *p < 0.01, ** p <0.001, NS, non-significant, unpaired t-test. 
 
To analyse the necessity of the histidines at 431, 456 and 458, numerous single or double 
alanine replacement mutants were synthesised and transfected into HEK293 cells stably 
expressing hMD2. In luciferase assays, single mutations at H431 and H458 had no impact 
on NF-B activation induced by Ni2+ while mutation at H456 rendered a partial decrease 
in Ni2+ responsiveness (Fig. 26). Contrastingly, all double mutants effectively diminished 
NF-B-dependent gene expression regulated by Ni2+ with the best inhibition ensuing upon 
mutation at the non-conserved human-specific H456 and H458 (Fig. 26). 
 
4.9 Histidines H456 and H458 in hTLR4 are required for Ni2+-induced 
proinflammatory gene expression 
 
 
 
Fig. 27: Immunoblot analysis of IL-8 protein in lysates. HEK293 cells stably expressing hMD2 were 
transfected with HA-tagged wild type or mutated hTLR4 constructs (hTLR4-H456A, hTLR4-H458A or 
hTLR4-H456A-H458A) and stimulated with medium (ctrl), Ni2+ (1.5 mM) or LPS (S. minnesota R595; 1 
µg ml-1). Equal loading was controlled by immunolabeling for tubulin. The immunoblot is representative of 
three independent experiments. 
 
Consistently, double replacement of histidines with alanine at 456 and 458 positions, 
diminished the Ni2+-induced IL-8 production significantly in various outcomes including 
western blot (Fig. 27), flow cytometry (Fig. 28) and ELISA (Fig. 29), while the single 
mutants H456 or H458 had very little or no effects, respectively. Interestingly, LPS 
induced gene regulation was not altered by any of the mutants (Fig. 26-29), demonstrating 
that LPS and Ni2+ require distinctive binding sequences for TLR4 activation.  
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Fig. 28: Flow cytometry of intracellular IL-8 staining for the indicated HA-positive cell population as 
identified by HA-co-immunostaining and appropriate gating (upper panel). HEK293 cells stably expressing 
hMD2 were transfected with HA-TLR4 constructs containing the indicated point mutations or empty 
expression vector as control. Cells were exposed to medium (Ctrl), Ni2+ (1.5 mM) or LPS (S. minnesota 
R595; 1 µg ml-1) for 8 h and subsequently processed for intracellular flow cytometry to detect IL-8. Black 
profiles represent IL-8 expression and grey profiles denote isotype controls. Flow cytometric quantification 
of averaged isotype-corrected median fluorescence intensities, MFI (lower panel) from three independent 
experiments ± s.d. Cells have been gated for positive transfection by anti-HA co-staining. 
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Fig. 29: ELISA analysis of IL-8 release in response to stimulation with Ni2+ (upper panel). Successful 
expression of the hTLR4 transgenes was confirmed by western blot for the HA-tag (lower panel). HEK293 
stably expressing hMD2 were transfected with HA-tagged TLR4 constructs containing the indicated point 
mutations or empty expression vector as control. Cells were exposed to medium (Ctrl), Ni2+ (1.5 mM) or 
LPS (S. minnesota R595; 1 µg ml-1) for 8 h and subsequently processed for ELISA to detect IL-8. Data are 
shown in relation to induction by LPS (arbitrarily set to 1) and represent averages ± s.d of three independent 
experiments. 
Double insertion of histidines in mTLR4 at 454 and 456 positions was sufficient to mimic 
the human situation. Indeed, expression of mTLR4 (Y454H-N456H) double mutant in 
HEK cells imparted a significant Ni2+ responsiveness (Fig. 30). From these experiments, 
it is very clear that distinctive amino acids in hTLR4 impose the observed species 
difference for Ni2+ recognition by cells of human and murine origin. 
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Fig. 30: Luciferase activity of a transfected 6κB-luc reporter in HEK293-hMD2 cells transfected with 
hTLR4, hTLR4 bearing inactivating alanine replacements at the putative metal-binding histidines (hTLR4-
H456A-H458A), murine TLR4 (mTLR4), or a “humanized” mTLR4 mutant containing histidine 
substitutions at the corresponding positions in the mouse sequence (mTLR4-Y454H-N456H), respectively. 
Cells were stimulated with medium (Ctrl), Ni2+ (1.5 mM) or LPS (S. minnesota R595; 1 µg ml-1) for 8 h. 
Data represent mean fold values of three independent experiments ± s.d. * p < 0.01, NS, not significant 
(unpaired t-test). 
 
 
4.10 Co2+ activates hTLR4/MD2 in a similar fashion to that of Ni2+ 
 
 
Fig. 31: Co2+-induced luciferase activity of a 6B-luc reporter upon transfection of HEK293 hMD2 cells 
with indicated constructs. Cells were stimulated with medium (Ctrl), Co2+ (1.5 mM) or LPS (S. minnesota 
R595; 1 µg ml-1) for 8 h. Bar diagrams represent mean fold values of three independent experiments ± S.D. 
* p < 0.05, ** p < 0.01, *** p <0.001, NS - not significant (unpaired t-test). 
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Fig. 32: IL-8 release measured by ELISA of supernatants from HEK293 hMD2 cells transfected with 
indicated constructs. Cells were stimulated with medium (Ctrl), Co2+ (1.5 mM) or LPS (S. minnesota R595; 
1 µg ml-1) for 8 h. Data represent averages of three independent experiments ± S.D. * p < 0.05, ** p <0.01, 
*** p < 0.001, NS, not significant (unpaired t-test). 
 
 
To evaluate if the Co2+-induced proinflammatory gene expression is also dependent on 
non-conserved histidines H456 and H458 of hTLR4, we used the previously generated 
alanine double mutants. Replacement of histidines with alanine at both 456 and 458 
positions delivered a striking reduction of Co2+ responsiveness in all the experiments 
including 6B-dependent promoter-reporter gene assay (Fig. 31), IL-8 ELISA (Fig. 32) 
or flow cytometry for IL-8 (Fig. 33).  
 
Contrarily, “humanized” mTLR4 (Y454H-N456H) expression in HEK293 hMD2 cells 
rendered responsiveness to Co2+ (Fig. 31, 32). From these experiments, it is very clear that 
Ni2+ and Co2+ activate the proinflammatory cascades in a similar fashion through TLR4 
activation followed by NF-κB stimulation. Remarkably, all the mutants were able to 
render responsiveness to LPS (Fig. 31-33), demonstrating that both the ligands require 
different sequences for TLR4 binding and activation. 
 
 
52 
 
 
 
 
Fig. 33: Flow cytometric staining of intracellular IL-8 protein expressed by the positively transfected cell 
population (upper panel). Transfection of the indicated constructs was monitored by HA-immunostaining 
and gating on the HA-positive population. Representative overlays of IL-8 staining (black lines) and isotype-
staining (grey lines) of three independent experiments are shown. Flow cytometric quantification (lower 
panel) of the staining (upper panel). Data represent means of isotype-corrected median fluorescence 
intensities (MFIs) of IL-8-staining calculated for the HA-gated population ± S.D. 
 
4.11 Metal allergens Ni2+/Co2+ facilitate hTLR4 homodimerisation independent of 
hMD2 
 
It is clearly understood that some TLRs can be activated as homodimers whereas some 
can function only as heterodimers [104]. The first step in TLR4 activation is its 
homodimerisation [115]. By using co-immunoprecipitation analysis, we evaluated the 
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capabilities of Ni2+ and Co2+, similar to LPS, to induce hTLR4 dimerisation. To this end, 
HEK293 WT or HEK293 MD2 cells were transfected with unique hTLR4 constructs 
coupled with either HA tag or FLAG tag or a combination of both. Subsequently, these 
cells were stimulated with Ni2+, Co2+ or LPS as control. A feeble band representing the 
basal interaction complex of HA-hTLR4 and FLAG-hTLR4 is seen in the -FLAG-
immunoprecipitations (IPs) of HEK293 MD2 cells co-transfected with HA-hTLR4/FLAG 
-hTLR4 (Fig. 34) but not in the IPs of single constructs.  
 
 
 
Fig. 34: HEK293 MD2 cells were co-transfected with the indicated combinations of HA- or FLAG-tagged 
TLR4 constructs and stimulated with medium (Ctrl), Ni2+ (1.5 mM), Co2+ (1.5 mM) or LPS (S. minnesota 
R595; 1 µg ml-1) for 30 min. Cell lysates were immunoprecipitated with -FLAG antibody and formed 
complexes visualized by immunoblot with an -HA antibody. Membranes were reprobed with -FLAG 
antibody to confirm equal immunoprecipitation. -HA and -FLAG western blots with total lysate are 
shown to illustrate similar transfection efficiencies. Immunoblots are representative of three to four 
independent experiments. 
 
 
 
Fig. 35: HEK293 WT cells were co-transfected with the indicated combinations of HA- or FLAG-tagged 
TLR4 constructs and stimulated with medium (Ctrl), Ni2+ (1.5 mM), Co2+ (1.5 mM) or LPS (S. minnesota 
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R595; 1 µg ml-1) for 30 min. Cell lysates were immunoprecipitated with -FLAG antibody and formed 
complexes visualized by immunoblot with an -HA antibody. Membranes were reprobed with -FLAG 
antibody to confirm equal immunoprecipitation. -HA and -FLAG western blots with total lysate are 
shown to illustrate similar transfection efficiencies. Immunoblots are representative of three to four 
independent experiments. 
 
Nevertheless, the hTLR4-MD2 heterodimer complex formation was significantly 
upregulated upon stimulation of Ni2+ or Co2+ or LPS. Strikingly, both the metal allergens 
aided the heterodimer alignment of FLAG-hTLR4 and HA-hTLR4 in the absence of MD2, 
whereas LPS was inept to do so (Fig. 35).  
 
 
Fig. 36: HEK293 MD2 cells were co-transfected with the indicated combinations of HA- or FLAG-tagged 
TLR4 constructs or TLR4 N433A constructs and stimulated with medium (Ctrl), Ni2+ (1.5 mM), Co2+  
(1.5 mM) or LPS (S. minnesota R595; 1 µg ml-1) for 30 min. Cell lysates were immunoprecipitated with  
-FLAG antibody and formed complexes visualized by immunoblot with an -HA antibody. Membranes 
were reprobed with -FLAG antibody to confirm equal immunoprecipitation. -HA and -FLAG western 
blots with total lysate are shown to illustrate similar transfection efficiencies. Immunoblots are 
representative of three to four independent experiments. 
 
 
Fig. 37: Analysis of metal allergen- or LPS-induced IL-8 production in supernatants from HEK293 MD2 
cells transfected with HA-hTLR4 or HA-hTLR4 N433A, respectively. The cells were stimulated with 
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medium (Ctrl), Ni2+ (1.5 mM), Co2+ (1.5 mM) or LPS (S. minnesota R595; 1 µg ml-1) for 8 h. Data represents 
mean ± S.D. of three independent experiments. *** p < 0.001 (unpaired t-test). 
 
 
The dimerisation domain of the hTLR4 has been vividly described by Park and colleagues 
in their crystal structure analysis [92]. To prove that receptor dimerisation is indeed critical 
for the TLR4 activation and downstream signaling, we replaced asparagine at 433 position 
with an alanine. This asparagine residue at 433 position in the dimerisation interface of 
hTLR4 is necessary during dimerisation for direct contact with the second TLR4 molecule 
[92]. HEK293 cells expressing hMD2 were transfected with combinations of HA-
hTLR4/FLAG-hTLR4, HA-hTLR4-N433A/FLAG-hTLR4 or HA-hTLR4-N433A/ 
FLAG-hTLR4-N433A and stimulated with medium, Ni2+, Co2+ or LPS, respectively. 
Cells were then harvested and lysates were utilised for co-immunoprecipitation 
experiments using -FLAG-IPs followed by an immunoblot with an -HA antibody.  
 
A steady decline in hTLR4 dimerisation is visible (Fig. 36) due to the mutation of a single 
or double N433 residue upon all the stimulants. In the end hTLR4 complex was 
untraceable not even a basal or stimulus-dependent complex when HA-hTLR4-N433A 
and FLAG-hTLR4-N433A were co-transfected. This shows that deficiency of both the 
N433 residues from the opposing TLR4 monomers is antagonistic for interaction or 
dimerisation. In concordance, HEK293-hMD2 cells transfected with HA-hTLR4-N433A 
could not trigger the release of more than basal level IL-8 upon Ni2+, Co2+ or LPS 
stimulations indicating that hTLR4 dimerisation is the first and foremost step essential for 
receptor activation by both metal allergens and LPS (Fig. 37).  
 
4.12 sTLR4 can inhibit Ni2+/Co2+-induced NF-B activation 
 
The presumed metal-binding histidines at 456 and 458 are in close proximity to the 
asparagine at 433 in dimerisation domain of hTLR4 [92]. Blocking off H456 and H458 
by using a peptide or small molecule inhibitor may hinder the LPS-induced dimerisation 
leading to sepsis in spite of the dispensability of both the histidines on LPS triggered 
hTLR4 activation [78]. The next alternative was to take advantage of the difference in 
MD2 requirement for hTLR4 dimerisation, which was the second distinguishing quality 
of both the stimuli. Therefore, we synthesized a soluble form of hTLR4 (sTLR4) 
comprising its ectodomain (aa 27-627) fused N-terminally to the signal peptide of the Igk-
chain to direct it to the secretory pathway [116]. This mutant was then transfected into 
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HEK293 cells resulting in an MD2-independent secretion of sTLR4 into the culture 
medium (Fig. 38). This conditioned supernatant medium was then collected and 
transferred onto the recipient cells, which were positive for hTLR4/MD2, to analyse the 
ability of the accumulated sTLR4 to block off the metal allergens- or LPS-induced 
proinflammatory responses. To our surprise, the addition of MD2-free sTLR4 conditioned 
medium hindered only the Ni2+ or Co2+ mediated IL-8 release when transferred to 
HEK293-TLR4/MD2 cells (Fig. 39) or HUVECs (Fig. 40) while the LPS triggered IL-8 
release was unaltered. 
 
Fig. 38: Western blot analysis of the indicated HA-tagged TLR4 proteins in supernatants and total lysates 
from transfected HEK293 WT cells. Data demonstrate MD2-independent release of truncated sTLR4 into 
the culture supernatant. Immunoblots are representative of three independent experiments. 
 
 
Fig. 39: IL-8 ELISA of HEK293 hTLR4/hMD2 cells incubated with undiluted supernatants produced by 
HEK293 WT cells transfected with the indicated constructs. Supernatants were taken 48 h after transfection 
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of the producer lines and freshly supplemented with medium (Ctrl), Ni2+ (1.5 mM), Co2+ (1.5 mM) or LPS 
(S. minnesota R595; 1 µg ml-1) for 30 min prior to addition to the HEK293 hTLR4/hMD2 cells and incubated 
for 8 h. Data represents mean ± S.D. of three independent experiments. ** p < 0.01 (unpaired t-test). 
 
 
Fig. 40: IL-8 ELISA of HUVECs incubated with undiluted supernatants produced by HEK wild-type cells 
transfected with the indicated constructs. Supernatants were taken 48 h after transfection of the producer 
lines and freshly supplemented with medium (Ctrl), Ni2+ (1.5 mM), Co2+ (1.5 mM) or LPS (S. minnesota 
R595; 1 µg ml-1) for 30 min prior to addition to the HUVECs and incubated for 8 h. Data represent mean ± 
S.D. of three independent experiments. ** p < 0.01 (unpaired t-test). 
In parallel experiments, neither sTLR4 H456/458A nor sTLR4-N433A mutant were able 
to block the metal allergen mediated IL-8 production indicating that the above-mentioned 
inhibition apparently required both metal-binding capacity as well as dimerisation ability 
(Fig. 39, 40). Therefore, the observed inhibition may depend on bonding of free metal 
ions to sTLR4 homodimers in the absence of free MD2.  
 
From the published crystal structure of hTLR4-MD2 heterodimer [92] and our own 
mutagenesis data, we hypothesize a structural model in which Co2+ or Ni2+ cross-links the 
two receptor monomers via specific histidine side chains triggering formation of a dimer 
that structurally resembles the one induced by LPS (Fig. 25, 41).  
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Fig. 41: Structural modeling of Ni2+ interaction with hTLR4. Modeling of the 2(Ni2+)-2(hTLR4)-2(MD2) 
complex in ribbon representation (side view) with the putative positions of the bound Ni2+ molecules 
indicated. The model is based on the crystal structure of the hTLR4-hMD2 complex (PDB entry 3FXI) with 
LPS omitted. Molecular modeling and graphics preparation was performed using PyMOL software. 
Interaction of Co2+ with hTLR4 resembles to that of Ni2+. 
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5 Discussion 
 
Skin diseases have a menacing socio-economic impact on the quality of life for millions 
of people worldwide. Particularly allergic responses to the metal allergens are the most 
common form of contact allergy in the developed countries. Moreover, metal allergy 
frequency is steadily increasing due to their wide distribution in a variety of products 
encountered in daily life ranging from metal coins, costume jewelry and body piercing to 
medical devices such as cardiovascular stents, orthopaedic and dental implants.  
For the development of contact allergies two signals are required, namely the T cell-
mediated signal and an adjuvant proinflammatory signal. However, it is currently unclear 
how allergy-relevant cells sense the presence of a contact allergen to trigger this co-
stimulatory response. Thus, in the present study we aimed at elucidating the cellular 
sensing mechanisms of the contact allergens Ni2+ and Co2+. 
In the periodic table of elements, Ni2+ and Co2+ reside in adjacent places and they share 
many similar chemical properties including the affinity to bind histidine [117]. Their 
atomic masses also are very much comparable namely 58.6934 and 58.9332 u, 
respectively. Both these transition metals are unique as they prefer to form a octahedral 
coordination geometry over tetrahedral or other geometries favored by other transition 
metal ions [118]. They also reside in neighboring places in the natural order of stability 
for divalent metals (Irving-Williams series). These two properties of Ni2+ and Co2+ are the 
two major contributing factors for selectivity of metal binding to proteins [119]. 
Convincingly, other divalent metal ions lacking allergic potential like manganese failed 
to activate NF-B in ECs in vitro [66]. Binding of Ni2+/Co2+ to hTLR4, in contrast to other 
divalent metal ions, is not simply a matter of balancing the charge but is mainly regulated 
by other physicochemical properties of the metal ion. The similarity in the mode of action 
between Ni2+ and Co2+ however fosters the possibility that contact with either of the two 
haptens may provide cross sensitization to the other, which may have critical 
consequences for preventing therapeutic approaches. In this context, it was recently 
established that Ni2+ acts as a strong adjuvant in Co2+ sensitization [120]. 
Sensitization to contact allergens involves a thorough assessment by resident skin cells 
[110]. We provide here the first evidence that major cell types of the skin like DCs, ECs 
and cells of the macrophage lineage possess the ability to react to metal allergens Ni2+ and 
60 
 
Co2+ by initiating an array of proinflammatory responses. The aforementioned cell types 
possess fully functional hTLR4 and MD2 as evidenced by their LPS responsiveness.  
A remarkable finding observed in this study was that keratinocytes, the predominant cell 
type of the epidermis, failed to respond to Ni2+ and Co2+. Furthermore, the expression of 
hTLR4 in keratinocytes is debatable as there is ample contradictory data [16, 17, 19, 121, 
122]. However, most of the studies are in concordance to our inference that primary human 
keratinocytes lack functional expression of hTLR4. Interestingly, the researchers who 
claim that keratinocytes express TLR4 were unable to show an LPS mediated 
proinflammatory activation except when employing unusually high concentrations of LPS 
like more than 100 μg ml-1 [19]. These concentrations are around 100-1000 times more 
than the concentrations needed to activate HUVEC or THP-1 cells in our studies. 
Nonetheless, if keratinocytes under some specific conditions express very little amounts 
of hTLR4, the level of expression is doubtful to be adequate to initiate the essential innate 
immune signal for sensitization to metal induced contact allergy. This situation opposes 
the established theory that keratinocytes play a vital role in the initial perception at least 
to these contact allergens [110].  
In the presence of a priming signal like TNF, keratinocytes may be yet able to initiate 
proinflammatory responses to extrinsic agents by the activation of inflammasome [123], 
a multi-protein complex linking innate immune receptors of the NACHT, leucine rich 
repeat, and PYD containing family (NLRP), which trigger the release of cytokines like 
interleukin-1 beta (IL-1) and IL-18 via a caspase-1-dependent mechanism [124]. 
Besides, keratinocytes are known to synthesise a large array of cytokines upon 
proinflammatory activation [125]. Therefore, keratinocytes may play vital role in the 
sensing of other contact allergens. Additionally, they may even exert regulatory functions 
or may have a role to play in the later phases of metal induced ACD.  
Gene silencing studies using RNA interference (RNAi) clearly showed the requirement of 
both TLR4 and MD2 for Ni2+/Co2+-induced proinflammatory gene expression. This is in 
accordance to the requirement of LPS, the natural ligand for TLR4. Potential 
contamination of Ni2+/Co2+ by LPS was excluded by the addition of polymyxin B sulphate, 
an LPS inactivating drug.  
The presently known more than 4000 contact allergens are able to initiate contact allergy 
though they depict a vast structural diversity among themselves. However, it is extremely 
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unlikely that they all have a common mechanism (e.g. direct proinflammatory activation 
of hTLR4) to induce ACD. Nevertheless, in a few instances a secondary mode of innate 
immune activation through TLR4 provocation has been proposed. It has been published 
that DNCB initiates CHS in mice by activating TLR2 and TLR4 by releasing a low 
molecular weight hyaluronan [83]. It is a very well recognized intrinsic activator of TLR2 
and TLR4 [126] generated by oxidative degradation of high molecular weight hyaluronan 
from the extracellular matrix (ECM). Another recently found mode of innate immune 
activation is via inflammasome pathway, which was mentioned in one of the earlier 
paragraphs. A recent study showed that Ni2+ can trigger IL-1β secretion by activating 
NLRP3-ASC-caspase-1 inflammasome complex [127]. To trigger inflammasome 
activation, a priming signal is required that not only elevates IL-1β expression but also 
induces expression of key inflammasome components. Only when this prerequisite is met, 
stimulus-induced NLR- and caspase-1 activation resulting in cleavage and release of  
IL-1β can ensue. In most cases, the priming signal is experimentally provided by LPS 
stimulation, suggesting a crosstalk of TLR4 signaling and inflammasome activation.  
Our critical outcome that both Ni2+ and Co2+ utilize a similar mode of action via hTLR4 
activation underlines the similarity of these two metal allergens seen in clinical studies 
[36]. Interestingly, we realized that Ni2+/Co2+-induced proinflammatory signaling 
cascades are species-specific and principally involve the non-conserved histidines at 456 
and 458 in hTLR4 but not in mTLR4. This newly identified species dependency of metal-
induced activation of hTLR4 resolves the obscurity why currently available murine 
models indispensably involve additional co-stimulatory agents or adjuvants for metal-
induced CHS [75, 128]. Supporting our findings, a recent study has shown that Co2+ 
released from metal-on-metal hip joint replacements can generate an endotoxin-like 
response by activating hTLR4 in neighboring immune cells [94]. Using a commercially 
available human reporter cell line stimulated with either LPS or Co2+ or Ni2+, they 
measured alkaline phosphatase secretion resulting from the activation of TLR4. In 
accordance with our results, their murine reporter cell line could only be activated by LPS 
but not by Co2+ or Ni2+.  In conjunction to our hypothesis, palladium was also indicated 
recently to initiate innate immune responses via a direct activation of TLR4 signaling [37]. 
Furthermore, using our mutagenesis data and the published crystal structure of the hTLR4-
hMD2 complex we propose a model of activation by Ni2+/Co2+. While neither the hTLR4 
H431-H456-H458 triplet nor the histidine doublet formed by the closely spaced H458 
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residues at the interface of two TLR4 monomers have the proper distances and side chain 
geometry to form a high affinity binding site, minor local conformational adjustments 
allow an interdigitated arrangement of the histidine side chains from both hTLR4 
monomers and, due to the increased structural flexibility in this mode of interaction, lead 
to two putative chelating sites for the metal ions at the interface. This model can nicely 
explain the complex role of the individual histidine residues that became apparent from 
the mutagenesis studies: elimination of a single histidine at any of the positions 431, 456 
or 458 alone had no or only minor effects on Ni2+/Co2+ responsiveness while substitution 
of any pair of histidine residues by alanine led to a loss of receptor activation.  
In support of our data, a recent study has proven that Ni2+ binds to H431, H456 and H458 
of the hTLR4 [129]. Using a 32 amino acid fragment of hTLR4 starting from 429 to 460, 
they provide a substantial mass spectrophotometric and NMR based evidences of Ni2+ 
binding to histidines. 
The hypothesized (Ni2+/Co2+)2-(hTLR4)2 complex can be designed without hindering the 
gross quaternary structure of the heterodimeric hTLR4 complex initiated by LPS. The 
published x-ray crystal structure of the LPS-hTLR4-MD2 complex has revealed that 
numerous already known hydrophobic and hydrophilic interactions promote dimerisation 
of the individual monomers. Even though strong chemical bonding is involved in the 
docking of Ni2+/Co2+ to the imidazole moieties of the histidines in hTLR4, the type of 
cross-linking between two TLR4 monomers induced by Ni2+/Co2+ leads to a structurally 
very identical stereo-dimer that is easily accessible for downstream signaling. As a result, 
proinflammatory gene cascades are triggered that finally leads to the co-stimulatory signal 
needed for effective sensitization and elicitation of ACD [130] (see Fig. 42).  
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Fig. 42: Proinflammatory signaling pathways activated by Ni2+/Co2+. For induction of contact allergy to 
Ni2+/Co2+ two signals are required: an antigen-specific, T cell-activating signal and a proinflammatory 
signal.  The latter signal is sensed by hTLR4/hMD2 resulting in the activation of NF-B and p38 and 
subsequent expression of cytokines, adhesion molecules and type I interferons. 
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Notably, the mode of action of these two metal allergens observed in this study differs 
from that of the one described for the major house dust mite allergen, Derp2 which 
activates TLR4 only in the presence of LPS [131], while Ni2+/Co2+-induced TLR4 
activation is independent of LPS. In addition, Derp2, which functionally mimics MD2, 
acts as a sensitizer for LPS rather than a direct activator of TLR4 signaling unlike 
Ni2+/Co2+. A very recent study has also provided evidences for binding of a cationic lipid 
nanocarrier molecule, diC14-amidine to hTLR4 dependent of MD2 [132].  
Remarkably, our data demonstrate that the important residues responsible for metal 
binding located in the ectodomain of TLR4 are unique and different from those reported 
for LPS. This may provide a novel lead in fostering exclusive compounds that specifically 
target these cross-linking in TLR4 with no interference to the other functionalities of the 
receptor. Thus, our study has a potential to contribute to innovative strategies for 
prophylaxis and improved therapeutic efficacy of ACD to Ni2+/Co2+ that are not anymore 
dependent on application of topical immunosupressants. Taking benefit of the unusual 
species preferences of TLR4 responses, our data strongly emphasizes that evaluation of 
allergenicity, toxicity of potent chemicals/allergens in rodent models might not correspond 
to the phenomenon in humans, and care should be taken to interpret those results. 
Our data from the dimerisation defective hTLR4 mutant clearly demonstrates that TLR4 
cross-linking is indeed essential for the metal-induced proinflammatory activation. Of 
note, the mutated asparagine residue at 433 position is in close proximity to the anticipated 
metal binding histidines namely H456 and H458 [92].  
Largely, our findings prove dimerisation of TLR4 as a conventional method of Ni2+/Co2+-
induced innate immune activation. Importantly, differing from LPS, cross-linking of 
TLR4 happened without the involvement of MD2 (Fig. 43). This remarkable finding may 
open new therapeutic frontiers as deduced from our sTLR4 blocking studies, while it also 
raises questions concerning the function of MD2 in the metal-induced activation of TLR4. 
However, a recent study by Oblak and colleagues established that MD2 aids the anchoring 
of TLR4 monomers by imparting supportive hydrophobic bonding that stabilizes the 
heterohexameric complex of TLR4-MD2-Ni2+/Co2+ in an appropriate confirmation 
leading to downstream signaling [133].  
From the clinical perspective, our experiments not only promise new treatment 
opportunities using sTLR4 variants or sTLR4-derived peptides but also warrant caution 
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about strategies directly targeting metal-binding to inhibit metal-induced hypersensitivity 
responses as such efforts are prone to affect LPS-induced TLR4 dimerisation and bacterial 
responses as well. 
 
 
 
 
Fig 43: Model for sTLR4-dependent inhibition of metal-induced proinflammatory gene expression. sTLR4 
sequesters the free metal ions independent of MD2, thereby blocking the membrane bound TLR4 mediated 
proinflammatory response. Conversely, LPS cannot mimic the situation, as its binding to TLR4 is MD2 
driven.  
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6 Summary 
 
Allergic contact dermatitis (ACD) caused by the metal ions Ni2+ and Co2+ affect almost 
one in five people in the western world. Sources for these metals include numerous day-
to-day products like metal coins, costume jewelry, body piercing, medical implants, hair 
dyes and ceramics. Moreover, both metals are widely used in the building, metallurgical 
and electronic industries classifying metal-induced ACD as major work-related disease 
with considerable impact on professional careers and working ability of affected 
individuals. Despite the undisputed need for specific and well-tolerated therapies, current 
treatment options are limited to the use of topical corticosteroids, which are prone to major 
side effects, particularly upon the long-term administration obligatory with those patients. 
 
Here, we dissected the molecular mechanism required for Ni2+-induced hTLR4 activation 
and extended our analysis to Co2+-induced proinflammatory responses. Using 
supplementation experiments in naturally hTLR4-deficent primary human keratinocytes 
and HEK293 cells we show that Co2+ resembles Ni2+ by activating hTLR4/MD2 in a 
species-dependent manner requiring presence of the non-conserved histidines H456 and 
H458 within the proposed metal-binding domain of hTLR4 that flanks its dimerisation 
interface. Using a novel dimerisation-mutant of hTLR4 we provide first direct evidence 
that metal allergens, similar to LPS, strictly require hTLR4 dimerisation to trigger 
proinflammatory gene expression. This confirms our structural model, which predicts 
hTLR4 activation to occur by bridging of two hTLR4 molecules simultaneously bound by 
two metal ions to the non-conserved histidines H456 and H458. Most importantly, 
however, we show here that Ni2+ and Co2+, in contrast to LPS, do not require MD2 to 
induce hTLR4 dimerisation since both metals readily induced complex formation of 
differently tagged hTLR4 proteins in co-immunoprecipitation studies with MD2-free 
HEK293 cells. We believe that this observation holds great potential for therapeutic 
exploitation since administration of a soluble form of hTLR4 (sTLR4) produced in the 
absence of MD2 was capable to significantly reduce Ni2+ and Co2+-induced cytokine 
production in metal-sensitive cells while LPS responsiveness remained unchanged.  
 
In summary, our data show that metal allergens differ in at least two aspects from LPS: 
For one, they strictly require presence of the non-conserved histidines H456 and H458 to 
activate hTLR4 and, secondly, they induce hTLR4 dimerisation independently of MD2. 
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Thus, our results may provide the basis for novel therapies that aim at specifically 
inhibiting metal-induced ACD in a clinically manageable way. 
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7 Zusammenfassung 
 
 
Allergische Kontaktdermatitis (ACD) verursacht durch die Metallionen Nickel und 
Kobalt stellt ein häufiges Gesundheitsproblem in den Industrieländern dar und betrifft fast 
ein Fünftel der Bevölkerung der westlichen Welt. Quellen für diese Metalle umfassen 
zahlreiche alltäglich Produkte wie Metallmünzen, Modeschmuck, Piercingschmuck, 
medizinische Implantate, Haarfärbemittel und Keramiken. Darüber hinaus sind beide 
Metalle in der Gebäude-, Metall- und Elektronikindustrie weit verbreitet, was die durch 
Metallionen verursachte allergische Kontaktdermatitis zu einer bedeutenden 
Berufskrankheit macht. Der Einfluss auf die Arbeitsfähigkeit und damit den beruflichen 
Werdegang der betroffenen Personen ist erheblich. Trotz des unbestrittenen Bedarfs an 
spezifischen und gut verträglichen Therapien sind die derzeitigen 
Behandlungsmöglichkeiten auf die Verwendung von topischen Kortikosteroiden 
beschränkt, welche vor allem bei der notwendigen längerfristigen Behandlung starke 
Nebenwirkungen verursachen.  
 
In dieser Studie haben wir den molekularen Mechanismus, welcher der nickelinduzierten 
hTLR4-Aktivierung zugrunde liegt untersucht und unsere Analyse auf die 
kobaltinduzierte proinflammatorische Immunantwort ausgedehnt. Mit Hilfe von  
Supplementationsexperimenten an natürlich hTLR4-defizienten primären humanen 
Keratinozyten und HEK293-Zellen konnten wir zeigen, dass Kobalt – analog zu Nickel – 
hTLR4/MD2 speziesabhängig aktiviert. Dabei ist die Anwesenheit der konservierten 
Histidine H456 und H458, welche die hTLR4 Dimerisierungsschnittstellen flankieren, 
innerhalb der vorher experimentell ermittelten Metallbindungsdomäne von hTLR4 
notwendig. Unter Verwendung einer neuartigen Dimerisierungsmutante von hTLR4 
liefern wir einen ersten direkten Hinweis darauf, dass Metallallergene - ähnlich wie LPS 
- eine hTLR4-Dimerisierung unbedingt benötigen, um die Expression von 
proinflammatorischen Genen auszulösen. Dies konnte mit unserem Strukturmodell 
bestätigt werden, welches prognostiziert, dass die hTLR4-Aktivierung auf 
Kreuzvernetzung zweier hTLR4-Moleküle beruht, wobei zwei Metallionen gleichzeitig 
an die konservierten Histidine H456 und H458 von zwei unterschiedlichen hTLR4-
Molekülen gebunden werden. Zustätzlich konnten wir zeigen dass Nickel und Kobalt - im 
Gegensatz zu LPS - zur hTLR4-Dimerisierung kein MD2 benötigen, da beide Metalle die 
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Komplexbildung unterschiedlich markierter hTLR4-Proteine auch in Co-
Immunpräzipitationsstudien mit MD2-freien HEK293-Zellen induzieren konnten. Wir 
glauben, dass diese Beobachtung ein großes Potential zur Entwicklung spezifischer 
Therapien besitzt, da die Verabreichung einer löslichen Form von hTLR4 (sTLR4), die in 
Abwesenheit von MD2 produziert wurde, sowohl die Nickel- als auch Kobalt-induzierte 
Zytokinproduktion in metallsensibilisierten Zellen signifikant zu reduzieren vermochte, 
während die zelluläre Antwort auf LPS unbeeinträchtigt blieb. 
 
Zusammenfassend zeigen unsere Daten, dass sich Metallallergene in mindestens zwei 
Eigenschaften von LPS unterscheiden: Zum einen benötigen sie unbedingt die 
Anwesenheit der nichtkonservierten Histidine H456 und H458, um hTLR4 zu aktivieren 
und zum anderen induzieren sie die hTLR4-Dimerisierung unabhängig von MD2. Daher 
können unsere Ergebnisse die Grundlage für neuartige Therapien liefern, die auf eine 
spezifische Hemmung von metallinduziertem ACD in einer klinisch leicht zu 
handhabenden Weise abzielen. 
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9 Abbreviations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACD  Allergic contact dermatitis 
BSA  Bovine serum albumin 
C  Celsius 
CHS  Contact hypersensitivity 
Co2+  Cobalt 
dd H2O Double distilled water 
DMEM Dulbecco’s Modified Eagle’s 
Medium 
DMSO Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
ds  Double strand 
DTT  Dithiothreithol 
dn  Dominant negative 
ECs  Endothelial cells 
E. coli  Escherichia coli 
ECL  Enhanced chemiluminescence 
EDTA  Ethylenediamine-tetra acetic 
acid 
ELISA  Enzyme-linked 
immunosorbent assay 
FBS  Fetal bovine serum 
FITC  Fluorescein isothiocyanate -
coupled 
h  Hour 
HRP  Horse radish peroxidase 
IKK I-κB kinase 
IL  Interleukin 
kDa  Kilodalton 
LPS  Lipopolysaccharide 
M  Molar 
mA  Milli ampere 
 
mg  Milli gram 
min  Minutes 
ml  Milli litre 
MyD88 Myeloid differential factor 88 
NF-B  Nuclear factor kappa-light- 
chain-enhancer of activated B 
cells  
Ni2+  Nickel 
OD  Optical density 
PAGE  Polyacrylamide Gel 
Electrophoresis 
PBS  Phosphate buffered saline 
PCR  Polymerase Chain Reaction 
PFA  Paraformaldehyde 
PMB  Polymyxin B sulfate 
pmol  Pico mol 
PRRs   Pattern-recognition receptors 
PVDF  Polyvinylidene difluoride 
RNA  Ribonucleic acid 
SDS  Sodium dodecylsulfate 
SEM  Standard error of the mean 
ss  Single stranded 
TBS  Tris buffered saline 
TBST  Tris buffered saline with 
tween 20 
TLB  Triton lysis buffer 
TLR  Toll-like receptor 
V  Volt 
g  Micro gram 
l  Micro litre 
m  Micro metre 
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